Effectiveness of task shifting in antiretroviral treatment services in health centres, Gasabo district, Rwanda by Kabeja, Adeline
i 
 
EFFECTIVENESS OF TASK SHIFTING IN ANTIRETROVIRAL TREATMENT 
SERVICES IN HEALTH CENTRES, GASABO DISTRICT, RWANDA 
 
ADELINE KABEJA 
Student Number: 2974499 
 
UNIVERSITY OF THE WESTERN CAPE 
Faculty of Community and Health Sciences, 
School of Public Health 
 
A mini-thesis submitted in partial fulfilment of the requirement for the degree of Masters 
in Public Health  
Health Workforce Development 
 
Supervisor: Professor Helen Schneider  
Co- supervisor: Dr. Rugigana Etienne 
July 2012
 
 
 
 
i 
 
KEYWORDS 
Human resources  
Nurses 
Task shifting  
Antiretroviral treatment  
Service delivery  
Health centres 
District Hospital 
Evaluation 
Effectiveness  
Rwanda 
 
 
 
 
ii 
 
ABBREVIATIONS 
AAHIVM American Academy of HIV Medicine 
AIDS acquired immune deficiency syndrome 
ART antiretroviral therapy 
ARV antiretroviral 
ASW adherence support workers 
CDC Centers for Disease Control and Prevention 
DH District Hospital 
DOTS Directly Observed Treatment Short Course 
ECSA-HC East, Central, and Southern African Health Community 
FHI Family Health International 
HC Health Centre 
HIV Human Immunodeficiency Virus 
HMIS Health Management Information System 
HRH Human Resource for Health 
HTC HIV testing and counselling 
IMAI Integrated Management of Adult and Adolescent Illness 
MOH Ministry of Health 
NGO non- governmental organization 
OI Opportunistic Infection 
PMTCT Preventing Mother-to-child Transmission 
 
 
 
 
iii 
 
LFW Lost to follow up 
PLHIV Person Living with HIV 
RBC Rwanda Biomedical Centre 
SD Standard deviation 
STI sexually transmitted infections 
TB Tuberculosis  
TRAC Plus Center for Treatment and Research on AIDS, Malaria, Tuberculosis and Other 
Epidemics 
TS Task shifting 
UNGASS United Nations General Assembly Special Session on HIV/AIDS  
UPDC Decentralization and Integration Unit 
WHO World Health Organization 
 
 
 
 
iv 
 
ACKNOWLEDGEMENTS 
I am very grateful to the Government of Rwanda, especially the Ministry of Health for the 
facilitation provided to achieve this Masters Degree. I would like to extend my gratitude to the 
World Health Organization, the National University of Rwanda/School of Public Health and the 
University of Western Cape/School of Public Health for providing me with a scholarship for this 
Masters Degree of Public Health. 
I would like to thank Prof. Schneider H., my supervisor and Dr Rugigana E., my co- supervisor 
for their guidance, ideas and inspiration. 
I would also like to thank the Director of Kibagabaga District Hospital and the Heads of the 
Health Centres where this study was conducted for their approval and support. I sincerely thank 
Mrs. Nkuliza A. and the health professionals who assisted me in data collection.  
Finally, I express thanks to my colleagues and friends; Uwaliraye P., Habagusenga J.D., 
Gatsinda M., Nyatanyi T., Muhimpundu A., Nyamusore J., Karuranga E.,Nshimiyimana E., 
Nizeyimana F., Uwiragiye A., and others that I have not mentioned for their support and 
assistance in one way or another.  
 
 
 
 
 
v 
 
TABLE OF CONTENTS  
KEYWORDS .................................................................................................................................. I 
ABBREVIATIONS ...................................................................................................................... II 
ACKNOWLEDGEMENTS ....................................................................................................... IV 
TABLE OF CONTENTS ............................................................................................................ V 
LIST OF TABLES ...................................................................................................................... IX 
LIST OF FIGURES ..................................................................................................................... X 
ABSTRACT ................................................................................................................................. XI 
DECLARATION...................................................................................................................... XIV 
CHAPTER 1: INTRODUCTION ................................................................................................ 1 
1.1 Description of task shifting program in ART services delivery in Rwanda .................... 4 
1.2 Problem statement ............................................................................................................ 6 
1.3 Description of study setting.............................................................................................. 7 
CHAPTER 2: LITERATURE REVIEW ................................................................................... 8 
2.1. Introduction ...................................................................................................................... 8 
2.2. Success of task shifting in HIV/AIDS service delivery at health centre level ................. 8 
2.3. Factors influencing the success of implementation of task shifting in ART services 
delivery .......................................................................................................................... 12 
2.3.1. Training of staff implementing task shifting .......................................................... 12 
2.3.2. Supervision and clinical mentoring ........................................................................ 13 
2.3.3. Motivation and retention of staff ............................................................................ 13 
2.3.4. Involvement of the community ............................................................................... 14 
2.3.5. Monitoring of quality of health care ....................................................................... 14 
2.4. Summary ........................................................................................................................ 15 
CHAPTER 3: METHODOLOGY ............................................................................................ 17 
 
 
 
 
vi 
 
3.1. Introduction .................................................................................................................... 17 
3.2. Study aims and objectives .............................................................................................. 17 
3.2.1. Aim ......................................................................................................................... 17 
3.2.2. Objectives ............................................................................................................... 17 
3.3. Study design ................................................................................................................... 18 
3.4. Definitions of key terms ................................................................................................. 21 
3.5. Study population ............................................................................................................ 23 
3.6. Sampling......................................................................................................................... 23 
3.7. Data collection methods ................................................................................................. 24 
Mean of CD4 cells count at initiation of ART ...................................................................... 26 
3.8. Validity/Reliability ......................................................................................................... 30 
3.9. Methods of data analysis ................................................................................................ 31 
3.10. Ethical considerations .................................................................................................... 31 
CHAPTER 4: RESULTS ........................................................................................................... 33 
4.1. Introduction .................................................................................................................... 33 
4.2. Background information ................................................................................................ 33 
4.2.1. Participation rate ..................................................................................................... 33 
4.2.2. Socio-demographic profile of patients .................................................................... 35 
4.3. Accomplishment of key task shifting activities, including training, and mentorship in 
catchment area of Kibagabaga DH ................................................................................ 37 
4.3.1. Training of nurses working in ART services delivery on task shifting .................. 37 
4.3.2. Training of District Hospital Mentors..................................................................... 38 
4.3.3. Mentorship and Supervision ................................................................................... 39 
4.3.4. Availability of job aids for providers of HIV care and treatment ........................... 40 
4.4. Accessibility to antiretroviral treatment to patients in need ........................................... 40 
4.4.1. Mean of patients initiated on ART by month ......................................................... 41 
4.4.2. Mean of CD4 cells count at initiation of ART ........................................................ 44 
4.5. The quality of care in ART service delivery at 13 HCs located in the catchment area of 
Kibagabaga DH.............................................................................................................. 45 
 
 
 
 
vii 
 
4.5.1. Quality of care in the cohort of patients initiated on ART between June and 
December 2010....................................................................................................... 45 
4.5.2. Quality of care in the 20 months period prior to and after task shifted care in 
overall ART program ............................................................................................. 47 
4.6. Patient outcomes ............................................................................................................ 47 
4.6.1. Outcomes for cohort of patients enrolled in ART program between Jun-Dec 2010
 ................................................................................................................................ 47 
4.6.2. Patient outcomes in overall program ...................................................................... 49 
CHAPTER 5: DISCUSSION ..................................................................................................... 50 
5.1. Accomplishment level of key task shifting activities..................................................... 50 
5.2. Extent to which task shifted care contributed to making ART accessible to patients in 
need ................................................................................................................................ 51 
5.3. The quality of care in ART service delivery based on task shifted care. ....................... 52 
5.4. Patient outcomes ............................................................................................................ 54 
5.5. Limitation of analysis: .................................................................................................... 56 
CHAPTER 7: CONCLUSION AND RECOMMENDATIONS ............................................. 57 
7.1. Conclusion ...................................................................................................................... 57 
7.2. Recommendations .......................................................................................................... 59 
REFERENCES ............................................................................................................................ 61 
APPENDICES ............................................................................................................................. 69 
Appendix 1: Data abstraction tools (english version) ................................................................ 69 
Appendix 1.1.: Data abstraction tool for district hospital, central level and partners ........... 69 
Appendix 1.2.: Data abstraction tool for the health centres .................................................. 71 
Appendix 1.3.: data abstraction tool for patient .................................................................... 75 
Appendix 2 : Outil de collecte des donnees (version française) ................................................ 77 
Appendix 2.1 : Outil de collecte des donnees pour l‘ hopital de district, le niveau central et 
les partenaires ......................................................................................................... 77 
Appendix 2.2 : Outil de collecte des donnees pour les centres de sante.................................... 79 
 
 
 
 
viii 
 
Appendix 2.3. Outil de collecte des donnees pour le patient ................................................ 84 
Appendix 3: Participant information sheet (English version) ................................................... 88 
Appendix 3.1. Confidentiality agreement ............................................................................. 88 
Appendix 3.2.: Participant information sheet ........................................................................ 91 
Appendix 3.3: Informed consent form .................................................................................. 94 
Appendix 4: Fiche d‘information aux participants (version française) ..................................... 95 
Appendix 4.1 : Accord de confidentialite.............................................................................. 95 
Appendix 4.2 : Fiche d‘information aux participants ............................................................ 98 
Appendix 4.4: Accord de consentement .............................................................................. 101 
Appendix 5: Addendum of data abstraction tool for the health centre .................................... 103 
 
 
 
 
ix 
 
LIST OF TABLES 
Table 1: Logic model of task shifting implemented at health centre level in Rwanda ................. 19 
Table 2: List of indicators evaluated, sources of data and method used ....................................... 25 
Table 3:Distribution of cohort of patients initiated on ART between Jun-Dec 2010 in 13 HCs, 
according to population size, sample size, sample analyzed and sample excluded from 
analysis (n=536) ............................................................................................................. 34 
Table 4: Background characteristics of the patient in cohort of patient initiated on ART between 
Jun-Dec 2010 (n=170) .................................................................................................... 36 
Table 5: Distribution of nurses working in ART services (n=36) and mean of patients newly 
enrolled per nurse across HCs (June 2010-January 2012, n=536) ................................. 41 
Table 6: Comparison of the means of patients newly enrolled per month across HCs before and 
after task shifting (before TS, n=1556 and after TS, n=1877) ....................................... 43 
Table 7: Distribution of baseline CD4 counts in the cohort of patients initiated on ART between 
Jun-Dec 2010 (n=170) .................................................................................................... 44 
Table 8: Descriptive analysis of quality of care in cohort of patients initiated on ART between 
Jun - Dec 2010 (n=170) .................................................................................................. 46 
Table 9: Outcomes by gender in the cohort of patients initiated on ART between June and 
December 2010 (n=170) ................................................................................................. 48 
 
 
 
 
x 
 
LIST OF FIGURES  
Figure 1: Levels of task shifting approach in ART services delivery (WHO, 2007) ..................... 3 
Figure 2: ART training status of nurses working in ART services delivery in 13 HCs located in 
Kibagabaga catchment area, January 2012, (n=36). ....................................................... 38 
Figure 3: Trend overtime of new adult patients starting ART in 13 HCs under supervision of 
Kibagabaga DH, (pre-TS care, n=1 556 ; post-TS care, n= 1 877) ................................ 42 
 
 
 
 
 
xi 
 
 ABSTRACT 
In the context of human resource crisis in African countries, the World Health Organization has 
proposed task-shifting as an approach to meet the ever-increasing need for HIV/AIDS care and 
treatment services. Rwanda started the process of task shifting towards nurse-based care in ART 
services in June 2010. After one year of implementation, a need to determine whether task 
shifting program has been implemented as intended and if it achieved its primary goal of 
increasing accessibility of people living with HIV to ARV therapy and improving nurse capacity 
in HIV patient care was imperative.  
A multi-method program evaluation study design, combining cross sectional, retrospective 
review and retrospective cohort sub-studies were used to evaluate the implementation, 
maintenance processes and outcomes of task shifting in 13 Health Centres (HCs) located in the 
catchment area of Kibagabaga District Hospital, in Rwanda. The study population consisted of 
HCs providing task shifted care (n=13), nurses working in the ART services of the 13 HCs 
(n=36), and more than 9,000 patients enrolled in ART care in the 13 HCs since 2006. All 13 HCs 
and 36 nurses were included in the evaluation. Routine data on patients enrolled in the pre-task 
shifting period (n=6 876) were compared with the post task shifting period (n=2 159), with a 
specific focus on data in the 20-months periods prior to and after task shifting. A cohort of 
patients 15 years and older, initiated onto ART specifically by nurses from June to December 
2010 was sampled (n=170) and data extracted from patients medical files.  
Data collection was guided by a set of selected indicators. Three different data collection tools 
were used to extract data related to planning, overall programmatic data and individual data from 
respectively, the program action plans/reports, HIV central databases and patients medical files. 
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Descriptive analysis was performed using frequencies, means and standard deviations (SD). The 
paired and un-paired t-tests were used to compare means, and chi-square test was used to 
compare categorical variables. To compare and to test statistical difference between two repeated 
measurements on a single sample but with non-normally distributed data, Wilcoxon signed rank 
test was used. To judge if current task shifted care is better, similar or worse than non-task 
shifted care, comparisons were made of program outputs and outcomes from the central database 
prior to and after the period of task shifting, and also with the cohort of nurse initiated patients.  
Results showed that 61% of nurses working in the ART program were fully trained and 
certificated to provide ART. Seven out of 13 HCs met the target of a minimum of 2 nurses 
trained in ART service delivery. Supervision and mentorship systems for the 13 HCs were well 
organized on paper, although no evidence documenting visits by mentors from the local district 
hospital to clinics was found. In term of accessibility, the mean number of patients newly 
initiated on ART per month in the HCs increased significantly, from 77.8/month (SD=22.7) to 
93.9/month (SD=20.9) (t test (df=38), p=0.025). A small minority of patients was enrolled in late 
stages of HIV, with only 15% of the patient cohort having CD4 counts of less than 100 cell /μL 
at initiation on ART. The baseline median CD4 cell count was 267.5 cells /μL in the cohort as a 
whole. With respect to quality of care, only 8.8% of patients in the cohort had respected all 
appointments over a mean follow up period of 17.2 months; and although follow up CD4 counts 
had been performed on the majority of patients (80%), it was done after a mean of 8.5 months 
(SD=2.7) on ART, and only a quarter (24.7%) had been tested by 6 months (as stipulated by 
guidelines). From central ART program data, a small but significant increase of patients on 2
nd
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line drugs was observed after implementation of task shifting (from 1.98% to 3.00%, 2=13.26, 
p<0.001), although the meaning of this shift is not entirely clear. 
The median weight gain was 1 kg and median CD4 increase was 89.5 cells /μL in the cohort after 
6 months of receiving task shifted care and treatment. These increases were statistically 
significant for both male and female patients (Wilcoxon signed rank test, p<0.001). With regard 
to loss to follow up, only three of the 170 patients in the cohort followed up by nurses had been 
lost to follow-up after a mean of 17.2 months on treatment. The routine data showed a decrease 
of patients lost to follow up, from 7.0% in the pre-task shifting period to 2.5% in the post-task 
shifting period. In general, the mortality rate was slightly lower in the post-task shifting period 
than in the pre-task shifting (5.5% vs 6.9% respectively), although this was not statistically 
significant (2=2.4, df=1, p=0.1209).  
This study indicates that, after over one year of implementation of task shifting, task shifting 
enabled the transfer of required capacity to a relatively high number of nurses. In an already well 
established programme, task shifting achieved moderate improvements in uptake (access) to 
ART, significant reductions in loss to follow up, and good clinical outcomes. However, 
evaluation of process quality highlighted some concerns with respect to adherence to testing 
guidelines on the part of providers and follow up visits on the part of patients. Improvements in 
processes of monitoring and follow up are imperative for optimal mid-term and long-term task 
shifting in the ART program. 
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CHAPTER 1: INTRODUCTION  
According to the World Health Organization (WHO) there is a global health workforce deficit of 
more than four million people (WHO, 2008). In many Sub-Saharan African countries and in 
parts of Asia and the Americas, the shortages are critical. At the end of 2006, the WHO 
estimated that there are 57 countries facing critical shortages of health workers, over half (36) of 
which are in Africa (Zachariah et al., 2008). An additional 2.4 million doctors and nurses are 
needed to meet the Millennium Development Goals.  
These human resource crises are aggravated by the rapidly increasing care needs generated by 
the HIV/AIDS epidemic in many African countries (Lehmann et al., 2009). In Sub-Saharan 
Africa, the human resource crisis is driven by emigration of trained health professionals, poor 
working conditions, poor salaries, low worker motivation, and high burden of infectious diseases 
(Zachariah et al., 2008).   
As one of several possible solutions to these human resource shortages facing the African public 
health sector, WHO proposed the task-shifting approach (Callaghan et al., 2010). Task shifting is 
―a process of delegation whereby tasks are moved, where appropriate, to less specialized health 
workers‖ (WHO, 2007, p.3).  
The delegation of tasks from one cadre to another less specialized is not a new concept (Dovlo as 
cited in Lehmann et al., 2009). It has been used in many countries as a response to emergency 
needs or as a method to provide adequate care in health system, especially in understaffed health 
facilities, (Lehmann et al., 2009). It is also common in high-income countries, the most known 
examples including nurse practitioners in the United States of America and nurse clinicians in 
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Sweden (Lewin et al. as cited in Philips et al., 2008). In several countries of Sub-Saharan Africa, 
specific cadres of non-physician health workers have been created to do clinical tasks in places 
where physicians are scarce, such as in rural areas. Besides these non-physician clinicians, well 
known examples of the use of lay workers include the community health worker and the 
community-based volunteer for giving directly observed treatment, short course (DOTS), for 
tuberculosis (Lewin et al. as cited in Philips et al., 2008). The concept of task shifting is 
increasingly promoted by WHO as a pragmatic response to health workforce shortages 
specifically to increase access to HIV services (WHO, 2008), after realizing that the western 
model of specialist physician management and advanced laboratory monitoring is not feasible in 
resource-poor settings (Gilks et al., 2006). According to WHO (WHO/PEPFAR/UNAIDS, 2008 
as cited by ECSA-HC. 2010:2), the task shifting approach in ART service delivery is 
summarized in the four following levels:  
- “Task shifting I: The extension of the scope of practice of non-physician clinical 
officers to enable them to assume some tasks previously undertaken by more senior 
cadres (medical doctors or specialists).  
- Task shifting II: The extension of the scope of practice of nurses and midwives to 
enable them to assume some tasks previously undertaken by senior cadres (non-physician 
clinical officers and medical doctors).  
- Task shifting III: The extension of the scope of practice of community health workers 
(CHWs), including PLHIV, to enable them to assume some tasks previously undertaken 
by senior cadres (nurses and midwives, non-physician clinical officers, and medical 
doctors).  
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- Task shifting IV: Patients, including PLHIV, trained in self-management, to assume 
some tasks related to their own care that would previously have been undertaken by 
health workers.‖  
 
Figure 1: Levels of task shifting approach in ART services delivery (WHO, 2007) 
In task shifting approach in ART service delivery, standardized simplified treatment protocols 
and decentralized service delivery enable lower level health-care workers to deliver HIV care 
and treatment to large numbers of HIV-positive adults and children (Gilks et al., 2006), while the 
senior cadres utilize the saved time to do other clinical services and supervise and/or mentor 
lower health care workers in their new role and responsibility.  
In Uganda for example (WHO, 2007), nurses are responsible for a range of tasks that were 
previously the responsibility of doctors. These include: managing people living with HIV who 
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have opportunistic infections; diagnosing tuberculosis sputum positive; prescribing medicine to 
prevent other infections; determining the clinical stage of people living with HIV; deciding 
whether people living with HIV have medical eligibility for antiretroviral therapy; and managing 
people on antiretroviral therapy who have minor side effects. In turn, tasks that were formerly 
the responsibility of nurses have been shifted to trained community health workers. These tasks 
include: HIV testing; counseling and education on antiretroviral therapy; monitoring and 
supporting adherence to antiretroviral therapy; filling in registers; triage; clinical follow-up; 
taking weight and vital signs; and explaining how to store antiretroviral drugs. The same 
scenario is observed in Rwanda and in most of African countries where the shifting approach 
was adopted in ART programs. In Rwanda, nurses prescribe first-line of ART regimens, manage 
ART-naive adult cases, and referral complex cases, while physicians manage complex medical 
cases, assure training/mentoring and supervise nurse-centered care (Shumbusho et al., 2009). 
1.1 DESCRIPTION OF TASK SHIFTING PROGRAM IN ART SERVICES DELIVERY IN RWANDA 
Rwanda started the process of task shifting in ART services delivery after a pilot project of 
decentralizing ART prescription by nurses initiated by Family Health International (FHI) in 
collaboration with the Rwanda Ministry of Health (MOH) in 2005. This pilot project found that 
nurses can effectively and safely prescribe ART when given adequate training, mentoring, and 
support (Shumbusho et al., 2009). 
Rwanda has a population of 10,412,820 (National Institute of Statistics of Rwanda, 2009). The 
national HIV prevalence among adults is 3%, but more than 7% in the urban areas (National 
Institute of Statistics of Rwanda and ORC Macro, 2006). According to the Rwanda 2010 HIV 
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and AIDS estimations and projections; 198,620 individuals were HIV infected while 96,040 
adults were eligible for ART (Mwumvaneza et al., 2010). By December 2009, 76,726 patients 
(adult and children) had initiated ART, for a national ART coverage of about 52% (TRAC Plus, 
2009 a.). This progress in ART scale-up has been made despite the significant shortages of 
health care workers. Indeed, the doctor to inhabitant ratio is 1 to 18,000 and that of  nurses 1 to 
1,690 (Mala, 2011). As the number of people on or needing ART and requiring long-term care 
has increased, it has become evident that the available pool of physicians cannot respond to the 
need.  
To address this, the MOH instituted task shifting in 2009. At central level, the program was 
designed by the former Center for Treatment and Research on AIDS, Malaria, Tuberculosis and 
Other Epidemics (TRAC Plus) through its Unit of HIV/AIDS and STI, and by the Ministry of 
health‘s Unit called Decentralization and Integration Unit. At district level, implementation 
involved Directors of District Hospitals (DH) and physicians, local and international non- 
governmental organization (NGO) partners operating in clinical HIV programs, and at health 
centre level, the heads of Health Centres (HC) and nurses as front-line staff. 
According to the task shifting implementation plan 2009-2010 (TRAC Plus, 2009 b.), the task 
shifting program was designed in three phases, namely: 1) determining needs and feasibility, 2) 
designing the implementation process and 3) evaluation. Among the key planned activities, there 
was the development of technical documents, a review of the staffing structure at the HC, and 
provision of training and mentoring. The goal was to increase accessibility of people living with 
HIV to ARV therapy and to improve nurse capacity in HIV patient care, including treatment with 
ARV, with all existing ART sites inducted in task shifting.  
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From February to June 2010, 856 nurses from 40 DH and their 389 health facilities were trained 
in the expanded scope of services. By June 2011, 705 (82.36%) nurses had been mentored and 
fully validated by physicians at their facilities and officially authorized to: prescribe the first line 
of ART; prevent and treat opportunistic infection (OI) and sexually transmitted infections (STI); 
manage patients with immunological and clinical failure; manage side effects and identify, 
manage and refer complicated cases (TRAC Plus, 2010). 
1.2 PROBLEM STATEMENT  
Although findings from pilot intervention of nurse-initiated ART at three rural primary health 
centres (HC) in Rwanda showed good quality of HIV care outcomes and significant promise to 
scale up HIV/AIDS care and treatment through task shifting approach (Price and Binagwaho, 
2010), we cannot underestimate the contribution of ideal working conditions created during the 
pilot intervention which may have led to the success of the pilot intervention. The same working 
conditions are not necessarily met in normal working conditions at HC level. After one year 
since the process of implementation of the task shifting program in ART service delivery by HCs 
started, we thus considered that it is time to evaluate the implementation process and 
maintenance phase of task shifting program, to determine whether the task shifting program in 
HCs has been implemented and is going as intended. In addition, we anticipate that the 
evaluation will identify improvements needed to be presented to help policy makers so 
adjustments could be done accordingly to ensure good quality of health care delivery.  Finally, 
this study will either support or refute the findings of other studies on effectiveness of task 
shifting in ART services delivery of HCs in Rwanda. 
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1.3 DESCRIPTION OF STUDY SETTING 
This evaluation of the task shifting program was conducted in 13 health facilities located in the 
catchment area of Kibagabaga District Hospital (DH). Kibagabaga DH is one of the two district 
hospitals of Kigali City. It is located in Gasabo District, has an area of 43.030 km² (58% of the 
municipality area of Kigali City) and covers an estimated population of 411,710 inhabitants 
(Kibagababa DH, 2009). At the end of the year 2009, a total number of 6,431 patients from 16 
health facilities (14 public HC and 2 private HC) under responsibility of Kibagabaga DH (427 
children and 6,004 adults) had initiated ART treatment (TRAC Plus, 2009 a.). 
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CHAPTER 2: LITERATURE REVIEW 
2.1. INTRODUCTION  
This chapter examines the literature on task shifting approaches in ART services in Rwanda and 
in other countries. Some promising task shifting models are presented and factors influencing 
implementation of the task shifting approach to reduce human resource constraints in HIV 
programs are discussed. The literature search was conducted using key terms used in the study 
(evaluation/effectiveness of task shifting, nurses prescribing antiretroviral treatment, human 
resources for health in HIV programs) and different databases, namely Medline, Google Scholar, 
Human Resources for Health. 
2.2. SUCCESS OF TASK SHIFTING IN HIV/AIDS SERVICE DELIVERY AT HEALTH CENTRE 
LEVEL 
Following the growing needs to extend HIV/AIDS care and treatment to more patients in need 
and in the context of the human resources crisis especially in African countries, several pilot 
programs on task shifting in ART service delivery have been implemented to see which model of 
task shifting can be adopted and to test the feasibility of task shifting in HIV/AIDS services 
delivery at primary health care level.  
Among these programs we can cite a comprehensive task-shifting program implemented as part 
of ART service expansion in Lusaka, Zambia which showed that ―over the short term, it is 
possible to expand ART services in settings of extreme health worker shortage without 
compromising HIV clinical care quality‖ (Morris et al., 2009). The feasibility of task shifting in 
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HIV/AIDS service delivery at primary health care level was also showed by others studies, such 
as the retrospective evaluation of a pilot program of nurse-centered antiretroviral treatment 
prescription implemented in three rural primary health centers in Rwanda (Shumbusho et al., 
2009), a prospective evaluation of the effectiveness of nurse led primary care based antiretroviral 
treatment by comparison with usual hospital care in a typical rural setting in Lubombo, 
Swaziland (Humphreys et al., 2010) and Médecins Sans Frontières‘ experience of scaling-up 
antiretroviral treatment in three sub-Saharan African countries (Malawi, South Africa and 
Lesotho), (Zachariah et al., 2008).  
Médecins Sans Frontières‘ experience concluded that the use of task shifting for HIV/AIDS care 
at two relatively new levels of the health system (health centres and the community) at Lusisiki 
in South Africa and Thyolo in Malawi did not affect the  quality of care and  was significantly 
associated with better ART outcomes (Zachariah et al., 2008). At Lusisiki, between January 
2004 and June 2005, 595 patients were registered at health centres while 430 were registered at 
hospital. At the end of June 2005, significant differences were observed on some outcomes like 
patients alive and on ART (81% at health centres compared to 67.2% at hospital); and patients 
lost to follow-up (2.2% in health centres versus 19.3% in hospital).  
A randomized non-inferiority trial study comparing outcomes of nurse versus doctor 
management of ART care for HIV-infected patients arrived at similar conclusions (Sanne et al., 
2010). This trial was conducted at two South African primary-care clinics. Patients were 
randomly assigned to nurse (n=404) or doctor (n=408) and compared with respect to ―treatment, 
limiting events‖ (referred to as treatment failure) including mortality, virological failure, 
treatment-limiting toxic effects, and adherence to visit schedule. The analysis showed that 48% 
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of patients in the nurse group and 44% in the doctor group reached an endpoint of treatment 
failure.. After a median follow-up of 120 weeks, deaths were 10 in the doctor group versus 11 in 
the nurse group, virological failures were 44 against 39 respectively in the doctors and nurses 
groups , toxicity failures were 68 against 66, and programme losses were70 against 63. All these 
findings were not significantly different in both  groups. Findings from this study tend to support 
the theory that supports delegating monitoring of ART to appropriately trained nurses. 
These pilot interventions and recent publications on task shifting suggest significant promise for 
using nurses in task shifting to advance universal access to HIV care and treatment (Price and 
Binagwaho, 2010).  
Different models of task shifting have been adopted in HCs to scale up ART without 
compromising quality of health care. Cohen and her collaborators describe in their article one 
model of nurse-driven ART for adults and children at primary health care level in Lesotho 
(Cohen et al., 2009). Here nurses were responsible for providing all primary health care and for 
integrating a full range of HIV/AIDS services. . With regards to management of HIV and ART, 
nurses were trained to meet their new responsibilities through intensive in-service theoretical and 
practical training.. They worked under supervision and mentorship of doctor or an experienced 
nurse clinician, who visited them on a weekly or bi-weekly basis to provide clinical mentorship 
on diagnosis and management of complicated cases. Analysis showed that, between 2006 and 
2008 80% of people newly initiated on ART were enrolled at primary care level. Annual 
enrolment more than doubled, with no major external increase in human resources. Patients 
(adults) outcomes after 12month of treatment and follow up  were satisfactory in terms of 
mortality (11% ), loss to follow up (8.8%)and program retention(80%). .  
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In Rwanda, the evaluation of task shifting to nurse-based ART has been limited to three rural 
primary health centers (Shumbusho et al., 2009). Analysis at 6 months after initiation on ART 
showed satisfying outcomes; retention in the system was 93%, deaths was 7% , proportion of 
patients lost to follow up was 1%, and none had stopped treatment .The mean CD4 cell count 
gained in the first 6 months after initiation on ART increased between 97 and 128 cells /ml, 
while the mean weight gained varied between 1.8 kg and 4.3 kg in the first 6 months. These 
patient outcomes in the Rwandan aforementioned pilot program compared favorably with those 
from an evaluation of the national ART program in Rwanda (Shumbusho et al., 2009). Indeed, 
patient retention at the facilities participating in the nurse-based pilot program was slightly 
higher than the national estimate of 87% for adult patients attending similar size health centers in 
Rwanda, where care is generally provided by physicians (Lawrence et al., 2009). Although 
mortality at 12 months was slightly higher in the pilot program (8.5% versus 7%), patients lost to 
follow up were substantially lower (0.3% versus 1%). 
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2.3. FACTORS INFLUENCING THE SUCCESS OF IMPLEMENTATION OF TASK SHIFTING IN ART 
SERVICES DELIVERY 
Despite the fact that pilot interventions of task shifting in ART services delivery have been 
successfully implemented in different African counties, the authors of these programs have also 
cautioned that offering ART is far more complex than simply dispensing pills. In Rwanda for 
example, the authors of evaluation of the ART task shifting pilot intervention in three rural 
health centers say that nurses can prescribe ART and manage ART patients when given adequate 
training, mentoring, and support (Shumbusho et al., 2009), while in Zambia additional to 
training, mentoring and continuous quality monitoring, task shifting implementation required the 
institution of new facility and human resource systems (Morris et al., 2009).  
Similarly, the Médecins Sans Frontières‘ task shifting experience in Thyolo district in Malawi 
showed that task shifting was accompanied by a number of service delivery supports, process 
improvements and staff incentives (Philips et al., 2008). 
As there are many factors that could influence implementation of task shifting and which could 
differ according to specific characteristics of countries, this literature review discusses some of 
those that are applicable to this study context.    
2.3.1. Training of staff implementing task shifting 
Staff implementing task shifting in ART service delivery cannot automatically be assumed to 
have mastered the skills that the program was intended to impart (WHO, 2008); it is for this 
reason that sustainable training plays an important role in the success of task shifting.  
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According to Morris et al. (2009), in their article on use of task-shifting to rapidly scale-up HIV 
treatment services, the Zambian Ministry of Health recognized that training focusing on task-
shifting was the foundation to scaling up HIV care and treatment. In this Zambian experience, 
nurses underwent ―triage‖ training which focuses on ―(1) patient assessment and management of 
urgent problems, (2) recognition of toxicities and severe illness, and (3) interpretation of 
laboratory investigations. Nurses then underwent advanced training on care of the stable HIV 
patient, similar to the Integrated Management of Adult and Adolescent Illness (IMAI) program.‖ 
(Morris et al, 2009:3) Peer educators were trained to provide health education, adherence 
counselling, assess vital signs, record demographic information, and provide guidance to families 
to disclosing HIV status to their infected children. (Morris et al, 2009:3).  
2.3.2. Supervision and clinical mentoring  
It is recognized that support for heath workers through supervision, mentoring and teamwork 
improves the quality of care across the spectrum of heath care (WHO, 2008). There are many 
documented examples of poor outcomes where health programmes have failed to invest in 
adequate supervision and support for heath workers (WHO, 2008).   
In Zambia, an intensive system of follow-up support by a team of local physicians, clinical 
officers and nurses was provided on-site on a weekly basis (Morris et al, 2009).  
2.3.3. Motivation and retention of staff  
In Africa, many facilities face difficulties in motivating and retaining health staff. Migration of 
health workers includes flows at numerous levels: international, rural-to-urban, from clinical to 
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administrative jobs, from public to the private or nongovernmental organization (NGO) sectors, 
or out of the health-care sector (Kinoti and Livesle, 2004). This is driven by a series of ―push‖ 
and ―pull‖ factors related to remuneration, working and living conditions and training and career 
prospects (Kinoti and Livesle, 2004). To tackle this threat, WHO recommends that countries 
carefully consider their packages of financial and/or non-financial incentives (WHO, 2008). 
2.3.4. Involvement of the community  
The scaling up ART has become highly dependent on recruiting from the pool of other, non-
professional HRH (Van Damme, 2006). In Uganda for example, involvement of community 
members and people living with HIV/AIDS not only in supporting adherence and follow-up but 
also in advisory structures such as the National Advisory Board of the Drug Access Initiative 
have been cited as important success factors  (Okero et al., 2003). 
Other examples of the influence of the community in the success of HIV programs is 
demonstrated in Zambia where deployment of adherence support workers (ASW) in adherence 
counseling and treatment retention not only enabled a significant shift in professional workloads, 
but also improved quality of care with loss to follow-up rates of new clients declining from 15% 
to 0% (Torpey et al., 2008).  
2.3.5. Monitoring of quality of health care  
There is a necessity of tracking the quality of care being provided following task shifting. Health 
authorities must institute a quality assurance framework that includes standardized training, 
supervision, certification, and regular assessments. The WHO-Commissioned Study on Task 
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Shifting shows that the need for quality assurance mechanisms is sometimes overlooked in 
countries that are implementing task shifting (WHO, 2008). The available evidence indicates that 
investment in a range of quality assurance mechanisms including the definition of roles and 
competencies, recruitment, training, continuing education, supervision and evaluation, is 
essential to the success of the task shifting approach (WHO, 2008).  
In Lusaka, Morris et al. (2009) reported how a comprehensive continuous quality assurance 
program focusing on evaluation of clinical care, was established. This program was coordinated 
by a central team of "quality assurance" nurses and data monitors who on a quarterly basis 
reviewed the following:  
- A laboratory report listing all critical values according to date  
- A treatment failure report.  
- Site-specific performance reports that included proportion of patients starting ART who had 
baseline laboratory results documented; proportion of patients on ART who had a repeat CD4 
count ordered at the appropriate time; patient retention in care; and proportion of eligible patients 
receiving prophylaxis of Pneumocystis carinii (jiroveci) pneumonia  (Morris et al., 2009). 
2.4. SUMMARY  
The studies described above are similar to the scope of our research. They focus on the overall 
patient and program outcomes as well as factors influencing the success of implementation of 
task shifting in sub-Saharan Africa where services for antiretroviral therapy have to scale up 
rapidly in the face of generalized human resource crises. However, most of information available 
on effectiveness of task shifting approach to expand ART and the associated factors are from 
pilot programmes, where participation in a closely monitored pilot project can itself increase 
 
 
 
 
16 
 
commitment from nurses (Shumbusho et al., 2009). Information on rollout of task shifting in 
ART services delivery beyond pilot sites is still limited.  
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CHAPTER 3: METHODOLOGY 
3.1. INTRODUCTION 
This chapter describes the methods used in this study, including the study design and study 
sampling. A description of data analysis is provided and finally, the issues of ethical 
consideration related to the study are described. 
3.2. STUDY AIMS AND OBJECTIVES 
3.2.1. Aim 
The aim of this study was to assess the implementation of task-shifting in ART service delivery 
in Health Centres (HC) in Gasabo District, Rwanda.  
3.2.2.  Objectives 
Objectives of this evaluation were to: 
1.  Describe key task shifting activities, including training, and mentorship in the catchment 
area of Kibagabaga District Hospital. 
2. Assess if implementation of task shifting in ART services of HCs is improving 
accessibility to antiretroviral treatment to patients.  
3. Determine the quality of care in ART service delivery of HCs where task shifting was 
implemented. 
4. Assess patient and program outcomes in ART program based on task shifted care. 
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3.3. STUDY DESIGN 
A multi-method program evaluation study design combining cross sectional, retrospective 
review and retrospective cohort sub-studies was used to evaluate the implementation, 
maintenance processes and outcomes of task shifting. This combination of study designs 
methods enabled us to understand the factors that may have led to strengths and/or weaknesses in 
program outcomes. The first step in designing this evaluation was to construct a logic model 
based on the Centers for Disease Control (CDC) guide for evaluation of public health program 
(CDC, 2005). Table 1 shows the logic model of implementation of task shifting in Rwanda, 
drawn up in order to define appropriate indicators for evaluation. 
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Table 1: Logic model of task shifting implemented at health centre level in Rwanda 
Inputs Activities Outputs Short term outcomes Intermediate 
outcomes 
Long term 
outcome 
Funds 
Adopted 
ministerial 
instructions  
Staff at central 
level  
Mentors at central 
and district 
hospital levels  
System of 
monitoring and 
Determine the new structure at 
HC (number and roles of staff)  
Delegate and train other health 
staff and/or lay workers on 
their new specific tasks  
Conduct full training of all 
nurses who have to be 
involved in task shifting 
process on HIV management 
and ART guidelines 
Ensuring effective referral 
Number of HC which have implemented 
a new structure (number and roles of 
staff) further to task shifting program  
Number of job descriptions for health 
staff and/or lay workers reviewed 
Number of other health staff and/or lay 
workers trained on their new specific 
tasks  
Number of staff oriented to the 
expanded role of nurses 
Number of nurses involved in task 
Improved organization 
of patients follow-up 
Improved quality of 
care in ART programs  
Fruitful referral 
system 
Improved patients  
outcomes  
Enhanced program 
retention 
Improved nurse 
capacity in HIV 
patient care, 
including 
treatment with 
ART.  
Increased 
accessibility of 
people living 
with HIV to 
ART therapy  
 
Change in 
morbidity 
and mortality 
of HIV 
patients 
Health 
systems 
strengthened  
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evaluation of 
ART program 
utilizing a Central 
Web-Based 
Database 
(TRACnet)  
Nurses at health 
centre levels  
Collaboration 
framework with 
clinical partners 
procedures and mechanisms 
Design and distribute job aids 
to be used by Prescribing 
Nurses 
Assure mentoring and 
supervision of nurses 
prescribing ART (twice a 
month) or any time needed  
Ensure immediate technical 
assistance to ART prescribing 
nurses if needed. 
Monitoring and evaluation of 
indicators for quality of care 
shifting process who have been fully 
trained 
Type of referral procedures and 
mechanism established 
Number of each type of job aids 
distributed to HC  
Number of supervisions/mentoring 
visits conducted in each HC 
High level provide assistance to ART 
Prescribing Nurses in case of complex 
issues as needed 
Number of patients receiving proper 
care 
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Evaluation was conducted on processes (activities), outputs and outcomes of task shifting in 
ART services delivery of 13 HCs under supervision of Kibagabaga DH, where the task shifting 
approach has been implemented since June 2010. It involved a cross sectional assessment of 
program activities as reported in program reports and documents; review of central program data 
(referred to as TRACnet) on all patients enrolled (by both doctors and nurses) during the 20 
months period prior to and after inception of task shifting, and evaluation of a cohort of patients 
specifically enrolled by nurses in the 13 HC based on retrospective record review.  
To judge if current task shifted care in Kibagabaga DH catchment area was better, similar or 
worse than non-task shifted care, comparisons were made of program outputs and outcomes from 
the central database considering 20 months prior to and after the task shifting, and also with the 
cohort of nurse initiated patients.  
3.4. DEFINITIONS OF KEY TERMS 
 Nurse fully trained: A fully trained nurse is a nurse working in ART services delivery, 
who was trained on task shifting (theory and practice) and who has a certificate 
authorizing her to prescribe ART. 
 Clinical mentoring: WHO defines clinical mentoring as ― a system of practical training 
and consultation that fosters ongoing professional development to yield sustainable high-
quality clinical care outcomes‖ (WHO, 2006) 
 Accessibility to antiretroviral treatment: the United Nations General Assembly Special 
session on HIV/AIDS (UNGASS) recommends using ―Coverage‖ as an indicator to 
measure ART access. The coverage is defined as the number of individuals receiving 
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ART at a point in time divided by the number of individuals who are eligible to receive 
treatment at the same point in time (including those who are already receiving ART). 
This is a cross-sectional measure, a ―snapshot‖ of the cumulative ART enrolment relative 
to the ―backlog‖ of unmet need, at a point in time (Johnson & Boulle, 2010). 
 Retention: Refers to patients who are known to be alive and receiving ART at the same 
clinic where they initiated ART at the end of 6 months follow-up. This means that 
patients who are documented to have died, been lost to follow-up, stopped treatment, or 
transferred are considered non-retained. 
 Lost to follow up: patients initiating ART at the site in the selected time period who were 
not seen at the clinic, or pharmacy, > 90 days after the date of their last missed 
appointment or their last missed drug pick-up, and who are not known to have transferred 
out or to have died (TRAC Plus, 2008). 
 Substitution: is defined as change from one ART regimen to another by substituting one 
or more ARVs within a drug class that was already used in the original regimen.  
 Switch: is defined as a change in an ART regimen after regimen failure. The change 
involves at least two new drugs; one of which is from a new ARV class.  
 Stop: is defined as a patient who has stopped ART treatment but is still in ART program. 
 Logic model: is a systematic and visual way to present and share your understanding of 
the relationships among the resources you have to operate your program, the activities 
you plan to do, and the changes or results you hope to achieve. 
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3.5. STUDY POPULATION  
The study population consisted of three sub-populations:  
- Health facilities under the supervision of Kibagabaga DH providing nurse-based task 
shifted care 
- Nurses providing antiretroviral treatment 
- Patients receiving task-shifted care 
3.6. SAMPLING 
The thirteen health centres under the supervision of Kibagabaga DH and providing nurse based 
ART and the 36 nurses working in the ART services of the 13 HC were all included in the study.  
Data on all patients who received ART in the 13 HC in the periods December 2006-May 2010 
(pre-task shifting) and June 2010-January 2012 (post task shifting) were extracted from the 
central database. The numbers for the two periods were 6 876 and 2 159 respectively. The sub-
set of patients enrolled or receiving care in the 20-month period (October 2008-May 2010) prior 
to task shifting were compared with the group in the 20-month period (June 2010-January 2012) 
after task shifting. 
Patients, 15 years and older, initiated onto ART by nurses from June to December 2010, 
constituted a cohort of patients for whom antiretroviral outcomes were assessed after 12 months 
or more on treatment. These were selected using a stratified random sampling procedure, with 
each HC constituting a stratum, as the effects of task shifting may be dissimilar in different HC. 
The proportion of patients to be selected in each stratum was determined by the size of patients 
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followed at each HC. Patients initiated on ART by physicians and patients who had been 
transferred from another HC were excluded from the sample. A total of 536 new adult patients 
were initiated on ART in the 13 health facilities during the period of June-December 2010. Thus, 
assuming that 70% of these patients received good quality of care with 66% as a worst 
proportion of patients who could receive good quality of care, a sample size of 214 patients was 
calculated at a confidence level of 90%, using Epi-Info version 3.5.1.  
3.7. DATA COLLECTION METHODS 
Data collection method was guided by a set of indicators, demonstrated in table 2, which were 
selected to orient the assessment of study objectives.  
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Table 2: List of indicators evaluated, sources of data and method used  
Study objective Indicators  Definition of indicator Source of data Method Population/ samples 
To describe the 
key task shifting 
activities, 
including training, 
and mentorship in 
catchment area of 
Kibagabaga DH  
Proportion of nurses in ART 
program who are fully 
trained  
Number of nurses fully 
trained / total number of 
nurses working in ART 
program 
- HC administrative 
documents 
- Training reports 
Cross sectional  Nurses providing 
antiretroviral treatment 
 
Proportion of mentorship 
visit or supervisions 
conducted according to the 
action plan of 2010 and 2011 
Number of mentorship visits 
or supervisions conducted in 
2010 and 2011 / number of 
mentorship visits or 
supervisions planned in 
2010 and 2011 
- Supervision and 
mentorship 
reports 
- Action plans 
(TRAC Plus, 
Decentralization 
unit, partners and 
DHs) 
Retrospective 
review  
13 Health facilities under 
supervision of Kibagabaga DH 
Types of task shifting job aids Availability of all job-aids Health centres Cross sectional 13 Health facilities under 
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available at HC at all HC  supervision of Kibagabaga DH 
To assess if 
implementation of 
task shifting in 
ART services of 
HC is improving 
accessibility to 
antiretroviral 
treatment to 
patients in need 
Trends over time of number 
of enrolments in ART 
program, before and after 
implementation of task 
shifting approach 
Mean monthly enrolment 
onto ART per HC pre and 
post task shifting periods 
TRACnet database  
 
Retrospective 
review 
Patients who received ART in 
the 13 HC in the periods Oct 
2008-May 2010 (pre-TS) and 
Jun 2010-Jan 2012 (post TS) 
Mean of CD4 cells count at 
initiation of ART 
Mean CD4 cells count at 
initiation of ART 
Patient medical file Cohort Patients, 15 years and older, 
initiated onto ART by nurses 
from Jun to Dec 2010 
To determine the 
quality of care in 
ART service 
delivery of HC 
where task shifting 
Percentage of patients on the 
2
nd
 line treatment before and 
after implementation of task 
shifting  
Number of patients on the 
2
nd
 line before and after TS / 
total number of patients on 
ART before and after TS 
TRACnet database  Cross sectional Patients who received ART in 
the 13 HC in the periods Oct 
2008-May 2010 (pre-TS) and 
Jun 2010-Jan 2012 (post TS) 
Percentage of patients Patients referred to specialty Patient medical file Cohort Patients, 15 years and older, 
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was implemented. referred to specialty medical 
services 
medical services / total 
number of patients on ART  
 initiated onto ART by nurses 
from Jun to Dec 2010 
Proportion of patient who 
substituted drugs 
Patient who substituted 
drugs/ total number of 
patients on ART 
Patient medical file Cohort Patients, 15 years and older, 
initiated onto ART by nurses 
from Jun to Dec 2010 
Proportion of patient who 
switched regimen 
Patient who switched 
regimen/ total number of 
patients on ART 
Patient medical file Cohort Patients, 15 years and older, 
initiated onto ART by nurses 
from Jun to Dec 2010 
Proportion of patient who 
stopped ART 
Patient who stopped ART/ 
total number of patients on 
ART 
Patient medical file Cohort Patients, 15 years and older, 
initiated onto ART by nurses 
from Jun to Dec 2010 
Proportion of patient who 
respected all appointments 
provided to them 
patient who respected all 
appointments provided to 
them/ total number of 
patients enrolled 
Patient medical file Cohort Patients, 15 years and older, 
initiated onto ART by nurses 
from Jun to Dec 2010 
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Mean of missed 
appointments per patient on 
ART  
(Number of appointments 
not kept per patient/ total 
number of appointment 
provided per 
patient)/months 
Patient medical file 
and appointment 
book 
Cohort 
 
Patients, 15 years and older, 
initiated onto ART by nurses 
from Jun to Dec 2010 
Proportion of patients with 
follow up CD4 counts 
Number of patients with 
CD4 counts at follow up 
assessment/total patients 
Patient medical file Cohort Patients, 15 years and older, 
initiated onto ART by nurses 
from Jun to Dec 2010 
Mean time at the first follow 
up of CD4 count 
Mean of months at the first 
follow up of CD4 count 
Patient medical file Cohort Patients, 15 years and older, 
initiated onto ART by nurses 
from Jun to Dec 2010 
To assess patient 
and program 
outcomes in task 
shifted care 
Mean of CD4/Weight gained 
after 6 month on ART 
Means at 6 months – means 
at baseline 
Medical patient file Cohort Patients, 15 years and older, 
initiated onto ART by nurses 
from Jun to Dec 2010 
Percentage of patients Number of patients who are ART register and Cohort Patients, 15 years and older, 
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retained in the program after 
+12 months on treatment 
alive and known to be 
receiving ART at the same 
HC where they initiated 
ART at follow-up/total 
number of patient enrolled 
Medical patient file initiated onto ART by nurses 
from Jun to Dec 2010 
Proportion of ART patients 
who transferred out 
Persons who were 
transferred out/ total number 
of patients on ART  
ART register Cohort Patients, 15 years and older, 
initiated onto ART by nurses 
from Jun to Dec 2010 
Percentage of ART patients 
who died  
Patient who died/total new 
patients enrolled 
Medical patient file Cohort Patients, 15 years and older, 
initiated onto ART by nurses 
from Jun to Dec 2010 
Percentage of ART patients 
who died before and after TS 
patients who died/ total new 
patients before and after TS 
TRACnet database Cross sectional Patients who received ART in 
the 13 HC in the periods Oct 
2008-May 2010 (pre-TS) and 
Jun 2010-Jan 2012 (post TS) 
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Programmatic data were extracted from databases using a data extraction tool for health centres 
(appendix 1.2.) while individual data were extracted using a data extraction tool for patients 
(appendix 1.3).  
This was done by a trained fieldworker, with supervision from the author. Patients who met 
inclusion criteria were identified from the ART register and their respective ID numbers noted; 
study subjects were selected randomly thereafter, and their medical files extracted. Data 
collection was done within a period of 17 working days (from February, 16
th
 to March, 07
th
 
2012). 
Finally, a data extraction tool for central level, district and partners (appendix 1.1) was used for 
gathering information related to training and mentorship/supervision planned and conducted 
from action plans and supervision reports. 
3.8. VALIDITY/RELIABILITY 
The data collection tools were translated into French in order to facilitate their comprehension. A 
pre-test of data collection tools was made in one HC located in Kigali that would not be included 
in the study to see complexity of the data extraction and availability of information in different 
sources. After the pretest, the tool for health facility was revised to add information related to 
nurse‘s responsibilities (appendix 5).  
Double data entry was performed in order to minimize data entry errors and therefore ensure a 
good quality of data. A data entry template was developed in Epi-Info with a built-in check that 
detected and alerted data entry clerk on any errors or inconsistency on the data set.  Before 
processing and analysis, the two databases were merged to identify any difference. In case of 
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inconsistency, it was checked for correction. If it was not possible to correct, the sheet with 
problem was excluded from the analysis. 
3.9. METHODS OF DATA ANALYSIS  
Data analysis was done using Epi Info version 3.5.1 and SPSS 17.0 software. Descriptive 
statistics analysis was performed using frequencies, percentages, means, median and standard 
deviations (SD). The paired and two-sample t-tests were used to compare means. To compare 
categorical variables, Chi-square test with P-value=0.05 as cut-off point for significance was 
used; while wilcoxon signed rank test was used to compare and to test statistical difference 
between two repeated measurements on a single sample but with non-normally distributed data.  
3.10. ETHICAL CONSIDERATIONS  
Permission to conduct the study at HC was requested from the Director of Kibagabaga DH while 
an informed consent sheet explaining in detail the nature of study, the reason it is being 
undertaken, and the possible benefit and potential risk of participation of HC in the study was 
presented to the Heads of HC who signed it before proceeding to data collection. To ensure 
anonymity, no patient names, patients ID or other unique identifiers were utilized in analysis. 
Each extraction sheet was given a unique study identification number which was composed by 
the combination of the code of Health Information Management System (HIMS) of the HC and 
sequential numbers of subjects randomly selected in each HC.  
Although we do not anticipate that all patients included in this study will directly benefit from 
the results, it is reasonable to assume that the majority of patients included in the study, those 
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who remain alive and on ART, will indirectly benefit from the study through improvements 
made in the quality of care.  Results of the study will be shared with all HCs involved in study. 
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CHAPTER 4: RESULTS 
4.1. INTRODUCTION 
In this chapter, the results are presented according to study objectives. The chapter starts with a 
descriptive account of the different study populations; thereafter achievements of the program 
with regards to training, mentorship and supervision of task shifting are presented. The results 
chapter continues by presenting data on access to ART and findings on a set of selected 
indicators to measure quality of care. The chapter ends by examining clinical outcomes (CD4 
count and weight) after six months on task shifted antiretroviral treatment and ART program 
outcomes pre and post task shifting. 
4.2. BACKGROUND INFORMATION 
4.2.1. Participation rate 
All 13 HCs and all 36 nurses working in ART services delivery of concerned HCs consented to 
participate in the study. As shown in Table 3, the number of nurses by HC varied between 2 and 
6, with a mean of 3 nurses per health facility. 
Of the cohort of patients initiated on ART between June and December 2010, information related 
to the clinical and medical aspects of 210 patients was extracted from the medical files, but only 
information of 170 (81%) patients was analysed (Table 3). During the data cleaning procedure, 
44 (19%) records were excluded from the database due to missing values on important study 
variables. When it was not possible to complete at least one missing variable or to correct any 
inconsistency, the record with the problem was excluded from analysis.  
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Table 3:Distribution of cohort of patients initiated on ART between Jun-Dec 2010 in 13 
HCs, according to population size, sample size, sample analyzed and sample excluded from 
analysis (n=536) 
Health facilities Distribution of 
patients newly 
enrolled 
Distribution of 
study sample 
size 
Distribution of 
sample 
analyzed 
Distribution of 
sample excluded 
from analysis 
Gihogwe HC 10 4 3 1 
Gikomero HC 12 5 5 0 
Jali HC 17 7 7 0 
Kabuye HC 31 12 11 1 
Kacyiru HC 102 40 31 9 
Kagugu HC 30 12 11 1 
Kayanga HC 16 6 5 1 
Kibagabaga DH 79 31 22 9 
Kimironko HC 132 52 42 10 
Kinyinya HC 62 24 19 5 
Nyacyonga HC 16 6 5 1 
Prison 10 4 2 2 
Rubungo HC 19 7 7 0 
Total 536 210 170 40 
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Data of all ART patients that are reported in the central database were also used. Based on this 
central data, a cumulative number of 9 035 adult patients had received care in the ART program 
of the 13 HCs (6 876 in pre-task shifting period and 2 159 in the post-task shifting period). Of 
these, 7 706 were still on ART at the end of January 2012 (5 845 patients enrolled in pre-task 
shifting and 1 861 in post-task shifting periods). In the 20-months periods prior to, and after task-
shifting, 1 556 and 1 877 new patients were initiated onto ART in the 13 HCs, respectively.  
4.2.2. Socio-demographic profile of patients 
Of the patients who were on ART before implementation of task shifting in the 13 HC, 63.8% 
were female and 36.2% were male. This gender profile did not change with implementation of 
task shifting (63.6% females vs. 36.4% males).  
We also observed a similar gender profile among the cohort of patients initiated on ART 
between June-December 2010, (65.3% females versus 34.7% males), (Table 4). The cohort‘s 
mean age was 37 years (standard deviation (SD), 9.4 years) and median age was 36 years (range 
22-72).  
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Table 4: Background characteristics of the patient in cohort of patient initiated on ART 
between Jun-Dec 2010 (n=170) 
Characteristics Variable Frequency % 
Gender Female 111 65.3% 
 Male 59 34.7% 
    
Age group 15-24 17 10% 
 25-34 52 30.6% 
 35-44 67 39.4% 
 45-54 27 15.9% 
 55-64 4 2.4% 
 65+ 3 1.8% 
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4.3. ACCOMPLISHMENT OF KEY TASK SHIFTING ACTIVITIES, INCLUDING TRAINING, AND 
MENTORSHIP IN CATCHMENT AREA OF KIBAGABAGA DH 
4.3.1. Training of nurses working in ART services delivery on task shifting 
According to official reports of training for task shifting, nurses working in ART services 
delivery of HC located in Kibagabaga DH catchment area were trained in early 2010 during the 
second phase of the national training (Mbituyumuremyi, 2010). 
The training curriculum was prepared by TRAC Plus, UPDC, Partners, and district hospitals; and 
was accompanied by the distribution of task shifting tools such as training modules, validation 
criteria and ART treatment guides for health providers. Nurses working in HIV services were 
trained on: 
- ART first line prescription and the follow up of HIV infected or HIV exposed patients. 
- Early identification of therapeutic failure in patients on ART 
- Identification and management of side effects 
- Screening STIs and TB using recommended tools  
- Use of new patient files and registers 
Training was conducted by TRAC Plus in collaboration with partners and UPDC. It was divided 
into two sessions (5 days of theory and 5 days of practicum). A pre-test and post test were done 
before and after training and participants were ―partially‖ validated if they obtained a score in the 
post-test of 70% and above. After the two weeks training, nurses partially validated were 
admitted into the mentorship phase where physicians from Kibagabaga DH assisted them to 
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carry out all activities related to task shifting, this intensive period of mentorship was closed by a 
full validation.  
By the end of January 2012, 22 (61%) of the 36 nurses working in the ART programs of 13 HC 
had been fully trained and validated; three nurses were still undergoing training and 11 (31%) 
nurses were not yet trained (Figure 2). 
 
Figure 2: ART training status of nurses working in ART services delivery in 13 HCs 
located in Kibagabaga catchment area, January 2012, (n=36). 
4.3.2. Training of District Hospital Mentors 
At the start of the task shifting program, the central level mentors (TRAC Plus clinical mentoring 
team) underwent training through an internationally certificated program with the American 
Academy of HIV Medicine (AAHIVM) (TRAC Plus, 2010). Following this, in September- 
October 2010, mentors from district hospitals were trained in order to allow them to be able to 
support their health centers. Mentors were trained on following aspects:  
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- Plan  for and conduct mentoring program at health centres  
- Mentorship at health center level 
- Early identification and better management of side effects 
- Early identification and better management of treatment failure and drugs resistance 
- New tools and guidelines in PMTCT, ART and STIs areas 
- HIV management in adolescents  
- TB/HIV integration (One stop services) 
- Development of  community based treatment program at HC catchment area  to support 
adherence   
- Identification and  management of complicated cases   
- Usage of mentoring /reporting tools  
- Plan and conduct onsite  refresher trainings for providers at HC 
4.3.3. Mentorship and Supervision  
Physicians working at Kibagabaga DH are assigned to mentor nurses working in ART services 
of HC on a weekly basis. They are expected to spend at least one day per week at assigned health 
centres, in order to support nurses as recommended in the task shifting program. However, no 
written evidence documenting whether these mentorship visits were done was found except a 
calendar of mentorship visits planned for every physician found at the DH.  
According to the Annual Supervision Report of Rwanda Biomedical Centre (RBC), teams of 
supervisors from the central level supervised DH and HC every quarter to ensure quality of HIV 
services (RBC, 2011).  
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4.3.4. Availability of job aids for providers of HIV care and treatment 
In accordance with the last guidelines of the World Health Organization (WHO) published in 
2006, the former TRAC Plus (Center for Treatment and Research on AIDS, Malaria, 
Tuberculosis and Other Epidemics) adapted five guidelines on provision of care and treatment to 
persons living with HIV/AIDS. The guidelines were distributed to all health facilities to improve 
the skills of health providers and to maintain quality of treatment and care offered in both public 
and private health facilities. During this study, all these guidelines were indeed found in the 13 
HCs where the study was conducted. Guidelines found included: 
- Guideline for the provision of comprehensive care to persons infected by HIV in Rwanda, 
version 2009 
- National standards and guidelines for the clinical prevention of HIV, version 2010 
- Norms and procedures for pediatric HIV/AIDS care and treatment in Rwanda, version 2010 
- Guideline for the management of opportunistic infections in adults with HIV/AIDS in 
Rwanda, version 2010 
- National guide on the care of sexually transmitted infections: Manual of care provider, 
version 2010 
4.4. ACCESSIBILITY TO ANTIRETROVIRAL TREATMENT TO PATIENTS IN NEED 
To analyse the extent to which implementation of task shifted care in ART service delivery at  
the 13 HCs contributed to the improvement of accessibility of ART to patients in need, the 
monthly mean of patients initiating ART and mean of CD4 cells count at initiation of ART were 
analysed. 
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4.4.1. Mean of patients initiated on ART by month 
In the period June-December 2010, the 36 study nurses enrolled a total of 536 patients, 
representing a mean of 2.6 patients (range 1-8) each per month (Table 5).  
Table 5: Distribution of nurses working in ART services (n=36) and mean of patients newly 
enrolled per nurse across HCs (June 2010-January 2012, n=536) 
Health Facility Nurses working in 
ART 
Mean of patients enrolled per nurse 
per month (June 2010-January 2012) 
Kibagabaga DH 2 5  
Kacyiru HC 3 8  
Kimironko HC 5 4  
Kinyinya HC 6 2  
Kagugu HC 2 4  
Jali HC 2 1  
Gikomero HC 2 1  
Rubungo HC 2 2  
Kabuye HC 2 3  
Nyacyonga HC 2 1  
Kayanga HC 2 1  
Gihogwe HC 4 1  
Prison HC 2 2 
Total 36  
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In the overall program, the trend of new adult patients initiated on ART shows both a small 
increase and a more consistent pattern of new enrollment after implementation of the task 
shifting approach, and this trend appears to continue in 2012 (Figure 3). The comparison of 
means of patients initiated on ART per months in the 20-months period before adoption of task 
shifting approach in 13 HCs, (Oct 2008-May 2010), and in the 20-months period after 
implementation of task shifted care in the same HCs (Jun 2010-Jan 2012), showed a statistically 
significant increase from 77.8/month (SD=22.7) to 93.9/month (SD=20.9) (t test (df=38), 
p=0.025).  
 
Figure 3: Trend overtime of new adult patients starting ART in 13 HCs under supervision 
of Kibagabaga DH, (pre-TS care, n=1 556 ; post-TS care, n= 1 877) 
When disaggregated by facility level, again comparing mean of patients initiated on ART per 
month during the 20 months of the pre-task shifting period and the 20 months of the post task 
shifting period, small increases were observed in 9 of 13 HC (significant increase in one HC – 
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Kacyiru) and small decreases in enrolment in the remaining 4 facilities (significant in Prison HC) 
(Table 6).  
Table 6: Comparison of the means of patients newly enrolled per month across HCs before 
and after task shifting (before TS, n=1556 and after TS, n=1877) 
Health Facility Mean of Patients 
enrolled per 
month before TS 
(SD) 
Mean of Patients 
enrolled per 
month after 
TS(SD) 
Mean 
difference 
P-value 
Kibagabaga DH 8.6 (4) 9.4 (3.9) 0.8 0.569 
Kacyiru HC 14.6 (7.8) 23.1 (8.6) 8.5 0.003 
Kimironko HC 14.7 (7.8) 18 (8.1) 3.3 0.193 
Kinyinya HC 9.4 (5) 10.8 (4.1) 1.4 0.448 
Kagugu HC 5 (2.6) 7.5 (4.7) 2.5 0.068 
Jali HC 3 (2.1) 1.6 (1.6) - 1.4 0.062 
Gikomero HC 2.1 (1.9) 1.4 (1) - 0.7 0.226 
Rubungo HC 3.8 (2) 4 (3.3) 0.2 0.843 
Kabuye HC 4.1 (2) 5.1 (2.9) 1 0.216 
Nyacyonga HC 3.2 (2.6) 1.8 (1.4) - 1.4 0.079 
Kayanga HC - 2.4 (1.3) 2.4 - 
Gihogwe HC 1.1 (2.9) 2.8 (3.1) 1.7 0.122 
Prison HC 7.4 (5.2) 3.1 (3) - 4.3 0.001 
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4.4.2. Mean of CD4 cells count at initiation of ART 
In the cohort of patient initiated on ART between Jun-Dec 2010, the median CD4 cell count was 
267.5 at the baseline (range 2 - 836) cells /μL. The CD4 cells count of the majority of patients in 
cohort (65.9%) fell between 150 cell /μL and 350 cell /μL (Table 7). Only 15% had CD4 counts 
less than 100 cell/μL. Twenty three patients (13%), fell above national eligibility criteria (CD4 
count <350cell/ μL). However, two of these, with baseline CD4 >500 cell/μL were pregnant at 
time of enrolment (PMTCT cases), and therefore eligible for immediate ART initiation (Table 7). 
Table 7: Distribution of baseline CD4 counts in the cohort of patients initiated on ART 
between Jun-Dec 2010 (n=170) 
Cell count/cell/μL Frequency Percentage Cumulative percentage 
>50 cell/μL 14 8% 8% 
50-99 cell/μL 11 6% 15% 
100-149 cell/μL 11 6% 21% 
150-199 cell/μL 21 12% 34% 
200-249 cell/μL 19 11% 45% 
250-299 cell/μL 30 18% 62% 
300-349 cell/μL 41 24% 86% 
350-399 cell/μL 10 6% 92% 
400-449 cell/μL 9 5% 98% 
450-499 cell/μL 2 1% 99% 
>500 cell/μL  2 1% 100% 
Total 170 100%  
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4.5. THE QUALITY OF CARE IN ART SERVICE DELIVERY AT 13 HCS LOCATED IN THE 
CATCHMENT AREA OF KIBAGABAGA DH 
To analyze quality of care in 13 HCs under the supervision of Kibagabaga DH, two approaches 
were used; namely descriptive analysis of quality of care within the cohort of patients initiated 
on ART between Jun-Dec 2010 and bi-variate analysis of quality of care indicators reported in 
the overall ART program database. 
4.5.1. Quality of care in the cohort of patients initiated on ART between June and 
December 2010 
The mean duration of follow-up for the cohort of patients initiated on ART between Jun-Dec 
2010 was 17.2 months by the end of January 2012. During this period of follow-up, only 15 
patients (8.8%) respected all appointments provided to them (Table 8). The mean number of 
appointments missed per patients was 3.6 appointments.  
At the time of assessment (February 2012), 80% of patients in the cohort had had a follow –up 
CD4 count (Table 8). The mean time from initiation of ART and first follow up CD4 count was 
8.5 months (SD=2.7). The second CD4 cell count was performed on time (at 6 months) for only 
42 (24.7%) of 170 patients. Of the ART patients whose dossiers were reviewed, 3.5% had been 
referred to other specialty medical services, mostly the TB program, 5.9% substituted drugs, 
1.8% switched regime and 0.6% stopped ART (Table 8).  
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Table 8: Descriptive analysis of quality of care in cohort of patients initiated on ART 
between Jun - Dec 2010 (n=170) 
Indicators Variables Freq % 
Patients referred to specialty medical services  Yes  6 3.5% 
No 164 96.5% 
 
Patient who substituted drugs  Yes 10 5.9% 
No 160 94.1% 
    
Patient who switched regimen Yes 
 No 
3 
167 
1.8% 
98.2% 
    
Patient who stopped ART Yes 1 0.6% 
No 169 99.4% 
    
Patients who substituted drugs, switched 
regimen and stopped ART 
Yes 
No 
14 
156 
8.2% 
91.8% 
    
Patients with CD4 count at assessment Yes  
No 
137 
33 
80.4% 
19.6% 
Patients who respected all appointments Yes  
No 
15 
155 
8.8% 
91.2% 
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4.5.2. Quality of care in the 20 months period prior to and after task shifted care in 
overall ART program  
One indicator reported in the ART central database was used to assess the quality of care in the 
13 HCs located in Kibagabaga DH, namely percentage of ART patients on second line drugs 
before and after task shifting. 
The proportion of patients on the 2
nd
 line treatment was 2% at the onset of task shifting and 3% 
20 months after implementation of task shifting. The difference of patients on the 2
nd
 line 
between the two period was statistically significant (2=13.26, (df=1), p<0.001). 
4.6. PATIENT OUTCOMES  
In addition to weight and CD4 cell count at baseline and after 6 months, the outcome measures 
of patients retained, transferred out, lost to follow-up, and died were assessed. 
4.6.1. Outcomes for cohort of patients enrolled in ART program between Jun-Dec 2010 
Of the 170 patients initiated on ART between Jun-Dec 2010, 163 (95.9%) were still retained in 
the ART program after a mean of 17 months of follow up. Three patients (1.8%) were lost to 
follow-up and 1 (0.6%) had died and 2 (1.2%) were transferred out (to other ART sites). 
In the whole cohort, the mean CD4 count was 248.9cell/μL at baseline and 365.3 cell /μL at first 
follow up test of CD4. The mean weight at baseline was 56.4 kg and 58.3 kg at the first follow 
up of weight. The mean of weight gained was 1.9 kg and the mean of CD4 cells gained was 
116.4 cell /μL (Table 10). The median CD4 cell count increased from 267.5 cells /μL to 364.5 
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cell /μL at follow up. The median weight was 55 kg (range 39 – 94 kg) at baseline and 57 kg 
(range 40 – 95 kg) at the first follow up. 
For both males and females there was a statistical significant increase in the means of CD4 cell 
count (paired t-test) and weight (Wilcoxon Signed Ranks Test) from baseline to follow up, 
(P<0.001), (Table 10). The mean of weight gained was 1.8 kg for females and 2.3 kg for males, 
while CD4 cells gained were 117.9 cell /μL for females and 113.4 cell/μL for males (Table 10).  
Table 9: Outcomes by gender in the cohort of patients initiated on ART between June and 
December 2010 (n=170) 
Gender Outcomes 
compared 
(baseline vs. at 
6 months)  
Mean at baseline  
indicator (SD) 
Mean at 6 months 
indicator (SD) 
Mean value gained 
after 6 months on 
ART (SD)  
P-value 
Weight Female 55.8 kg (9.8) 57.5 kg (10.1) 1.8 kg (4.7) P<0.001 
 Male 57.5 kg(9.4) 59.8 kg (9.2) 2.3 kg (3.6) P<0.001 
 Cohort  56.4 kg (9.7) 58.3 kg (9.9) 1.9 kg (4.4) P<0.001 
      
CD4 Female 265 cell/μL (130.8) 383 cell/μL (195.9) 117.9 cell/μL (157) P<0.001 
 Male 218.6 cell/μL (110.7) 332 cell/μL (180.2) 113.4 cell/μL (161.4) P<0.001 
 Cohort 248.9 cell/μL (125.8) 365.3 cell/μL (191.6) 116.4 cell/μL (158.1) P<0.001 
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4.6.2. Patient outcomes in overall program  
4.6.2.1. Loss to follow up  
During the pre-task shifting period (20 months before TS), 444 patients were lost to follow up, 
representing 7% of all ART patients registered in the 13 HCs during the period. In the 20 months 
after implementation of task shifting (Jun 2010 - Jan 2012), 194 (2.5%) of patients were lost to 
follow up.  Although the mean monthly loss to follow up was much higher in the pre-TS period 
(22.9 with SD=40) than in post-TS period (9.7 with SD=13.2), this was not significant on the 
two-sample t test (p=0.19). However, comparisons of total loss to follow up for the two periods 
(the 20-months periods pre-TS and post-TS) as a ratio of total patients registered in each of these 
periods found highly significant differences (2=165.8, df=1, p<0.001).   
4.6.2.2. Deaths 
In the pre-task shifting period (20 months before TS), 107 deaths were recorded by the 13 HCs; 
while in the period of 20 months after implementation of task shifting (Jun 2010 - Jan 2012), 104 
deaths were recorded.  The mean monthly deaths were not statistically different between pre-and 
post- TS periods (p=0.9); (5.3 deaths per months (SD=5) in all 13 HCs in pre-TS versus 5.2 
deaths per months (SD=3) in post-TS). Comparisons of total deaths during the period, and using 
newly enrolled patients as the denominator (on the assumption that most deaths occur early in 
treatment), showed slightly higher deaths rates in pre-TS versus post-TS periods (6.88% vs 
5.54%), but was not statistically significant on chi-squared test (2=2.4, df=1, p=0.1209).  
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CHAPTER 5: DISCUSSION 
In this chapter main study findings are evaluated against national and WHO guidelines / targets. 
They are compared to available literature from other similar studies in terms of results and 
methods used. The relationship between study findings and what was expected is discussed and 
alternative explanations of results are provided where relevant. Finally, study limitations are 
highlighted.  
5.1. ACCOMPLISHMENT LEVEL OF KEY TASK SHIFTING ACTIVITIES 
This study revealed that all guidelines were developed and they are available at HC level as 
intended.  Training was well structured, although not fully conducted. Indeed, 22 nurse (61%) 
working in ART programs of 13 HCs had been fully trained and validated in the scope of HIV 
task shifted care and treatment. Six HCs out of 13 had less than 2 nurses trained in their ART 
service delivery. This finding is comparable to results of a cross sectional survey conducted in 
Uganda which assessed the national training needs for clinicians working in antiretroviral 
therapy clinics, which revealed that 62% of nurses who prescribe ART were trained in initiating 
patients on antiretroviral therapy (Lutalo et al., 2009). However the training approach in the two 
countries seems to be different. While in Rwanda the task shifting trainings are organized in one 
package of two weeks including theoretical and practicum for all nurses working in the ART 
program, in Uganda trainings and the curriculum were not standardized. The task shifting 
training in Kibagabaga DH catchment area was not conducted by accredited nursing institutions 
as it is in South Africa, (Dohrn et al., 2009). 
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The systems of mentorship and mentor training are well developed, but it was not clear how 
much they were adhered to. In South Africa, nurse mentors receive intensive training in HIV 
prevention, care, and treatment in order to be able to provide continuous hands-on mentoring to 
colleagues at the health facility level (Dohrn et al., 2009). Despite the fact that mentorships and 
mentor training are well organized in Kibagabaga DH, however, no strong evidence 
documenting that these mentorship visits were done by mentors from the DH was found except a 
calendar of mentorship visits planned for every physician, which was found at the DH.  
5.2. EXTENT TO WHICH TASK SHIFTED CARE CONTRIBUTED TO MAKING ART ACCESSIBLE 
TO PATIENTS IN NEED 
This study shows an increase in new enrollment after implementation of the task shifting 
approach which is an indicator of greater accessibility to ART.  This study finding is similar to 
results of the task shifting experience of Thyolo District Hospital in Malawi, where shifting ART 
initiation and follow-up from doctors to clinical officers and medical assistants doubled the 
number of patients enrolled onto ART treatment from 130 to 250 patients per month in the 
hospital (Bemelmans et al., 2010). Several other studies have also reported an increase in access 
to ART through task shifting. In Lusikisiki, South Africa, access to ART was achieved within 2 
years with a task-shifted approach in ART program, (Bedelu et al. (2007). Similarly, scale up has 
been reported in Mozambique where patients on ART increased from 17,343 (32 sites) in 
October 2005 to 82,587 (209 sites) in October 2007 (Assan et al., 2008).  
Task shifting in the 13 HCs of Kibagabaga DH catchment area is built on an already established 
doctor-based ART service. This possibly accounts for the slightly less pronounced increases in 
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enrolment with task shifting compared to other studies, and the fact that CD4 count levels were 
relatively high at enrolment. This is an indication of good program functioning in term of 
accessibility, meeting the WHO recommendation that advises services start ART earlier with a 
high level of CD4 cell count so as to avoid death, disease progression and HIV transmission 
(WHO, 2009).  
One of the interesting findings of the study was the considerable facility level variation in 
enrollment rates (Min: 1 patient/month; Max: 23 patients /month).  The reasons for this could be 
the socio-economic profile of Kibagabaga DH catchment area which is composed by a region 
with predominant urban pattern and another region with a predominant rural pattern, while the 
Demographic Health Survey in Rwanda conducted in 2012 showed that the HIV prevalence in 
urban areas is more than three times than in rural areas (7.1% versus 2.3%), (NISR et al., 2010).  
5.3. THE QUALITY OF CARE IN ART SERVICE DELIVERY BASED ON TASK SHIFTED CARE.  
The analysis of quality of care within the cohort of patients initiated on ART between Jun-Dec 
2010 in the 13 HCs located in Kibagabaga DH catchment area showed poor quality of follow up 
in general. The proportion of patients who attended all clinical appointments was very low. 
Respect of clinical appointments has been shown to be associated with medication adherence 
(Choo et al., 1999). This study did not explore reasons for this low level of adherence to follow-
up visits or whether this resulted in interrupted supplies of treatment.  The literature review 
suggests several reasons for poor adherence to follow up visits; ranging from low knowledge of 
benefit, travel outside of patient‘s place of residence, being busy with other things, forgetting, 
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employment, confidentiality issues, distance from the health center, economic problems or being 
too sick and unable to travel (Horizons/Population Council, 2004). 
In addition to poor quality of follow up visits, analysis also revealed an inadequate level of 
follow up CD4 count testing. The national guideline for HIV treatment and care recommends 
checking every 6 months if CD4 cells are > 500 cell/μL or every 3 months if the CD4 cells are 
<500 cell/μL, in order to predict on time the risk of opportunistic infection or death and to act on 
this. Analysis of CD4 follow up was limited by the fact that this study did not explore reasons 
that could explain the inadequate level of follow up CD4 count testing and did not establish the 
situation before task shifting; but they are possibly similar to the reasons for low adherence to 
follow-up visits cited above.  
Concerning the proportion of patient in the cohort whose regimen was stopped, switched and 
substituted, this study found a relatively high proportion (8.2%). WHO recommends maintaining 
this proportion at close to 0% during the first 12 months after initiation on ART in order to 
prevent HIV drug resistance (WHO, 2010). However, the proportion of patients who switched 
regime and those who substituted drugs are similar to findings from a cohort study conducted at 
Hannan Crusaid Treatment Centre (HCTC), a clinic for Nyanga District in South Africa between 
Sept 2002 and Sept 2005 (Orrell et al., 2007). The findings also suggest an active role being 
played by nurses in clinical assessments and adjustment of treatment. 
This was also reflected in overall ART program data, showing increased switches to 2
nd
 line 
drugs after implementation of task shifting. The reasons for this are unclear – they could be a 
consequence of poor follow-up and therefore low medication adherence and therefore loss of 
effectiveness of 1
st
 line regimens. Improvements related to compliance with HIV care and 
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treatment guidelines, respect of clinical appointments, medication adherence and retention, are 
imperative to prevent HIV drug resistance which can be a public health threat, especially in the 
context of Rwanda, where in case of failure of these 2 treatment lines, it is not easy to access to 
the 3
rd
 line treatment which is much expensive.  
5.4. PATIENT OUTCOMES 
In the cohort of patients initiated on ART between Jun-Dec 2010, analysis revealed a significant 
change of mean weight and mean CD4 at 1
st
 follow up of weight and CD4 for both female and 
male. In comparison with findings from the previously conducted evaluation of clinical and 
immunologic outcomes from the national antiretroviral treatment program in Rwanda, conducted 
in 2004 – 2005 when only physicians prescribed ART, the study found slight lower median 
weight change and median CD4 cells change at the first follow up. While the median change was 
of 3 kg and the median CD4 change was 98 cell /μL in ART program with care and treatment 
done by physicians (Lawrence et al., 2009), the median weight change was 1 kg and median 
CD4 change was 89.5 cells /μL for the ART program based on task shifted care and treatment. 
This slight difference of weight and CD4 changes, were noted despite the similarities observed 
on socio-demographic characteristics of both study populations. Unfortunately our study did not 
explore factors associated to CD4 and weigh changes, but alternative explanations could be 
higher baseline CD4 counts, and a therefore less clinical need in the patient population of task 
shifted care. Others studies that explored this subject found that the adherence to medication and 
lifestyle are key factors to positive treatment outcome in the therapy of HIV/AIDS (Osterberg L, 
Blaschke T., as cited in Kenneth et al., 2009).  
 
 
 
 
55 
 
Despite poor adherence to follow up visits, a positive finding was the low proportion of patients 
lost to follow up in the cohort and the apparent decrease in patients lost to follow up in the 
overall ART program after task shifting. In comparison with the recommended target of WHO to 
prevent HIV drug resistance (<20%), the proportion of patients lost to follow-up in the 13 HCs 
located in the catchment area of Kibagabaga DH was good.  Task shifted care did not result in 
any increase in mortality rates.  
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5.5. LIMITATION OF ANALYSIS: 
Following are the main limitations of this study: 
- There was no control group in this study and without control groups it was not possible to 
say whether trends found would have occurred anyway. Ideally, this study should have 
compared a cohort pre and post task shifting, but due to financial limitations, we didn‘t 
do it. 
- The fact that some data (e.g. data related to mentor visits) relied on documentary sources, 
in future such sources can be supplemented by interviews with health facilities when 
supervision and mentorship training were conducted (e.g. number of mentor visits in last 
4 weeks).  
- This study did not explore factors associated with low level of adherence to follow-up 
visits and inadequate CD4 count testing follow up. Interviews with patients would have 
brought greater clarification, but time and financial aspects limited this. 
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CHAPTER 7: CONCLUSION AND RECOMMENDATIONS  
7.1. CONCLUSION  
Assessment of the implementation of task-shifting in ART service delivery in 13 health facilities 
located in the catchment area of Kibagabaga DH in Gasabo District – Rwanda, allowed us to 
conclude that, key task shifting activities were implemented; guidelines and job-aids were 
developed and provided to end-users as intended, but there is a need to make improvements 
especially on training and mentorship activities in order to successfully implement task shifting 
as planned. 
Trainings in scope of task shifting were well structured, although coverage was incomplete, and 
the systems of mentorship and mentor training are well developed, but it is not clear how much 
they are adhered to. Strong mentoring and supervision systems are vital to the success of task 
shifting.   
Task shifting increased new enrollment and therefore it assured better accessibility to ART. This 
positive indication of good program functioning was confirmed by the fact that few people 
started ART in late stages.  
Concerning the quality of care, the study revealed a poor quality of patients follow up especially 
in terms of follow up of clinical appointments and follow up of CD4 count testing. In addition, a 
fair proportion of patients switched regimens and substituted drugs, possibly when it was not 
necessary. However, clinical outcomes were overall satisfactory, and moreover, task shifting 
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appeared to reduce the proportion of patients lost to follow up and did not result in increased 
mortality rates. 
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7.2. RECOMMENDATIONS  
Based on the study findings, the following recommendations were formulated to improve nurse 
capacity in order to continue to make accessible HIV care and treatment and to provide the 
quality of care required for better patients‘ outcomes: 
 Organize regular trainings targeting new staff appointed in ART program delivery and 
design refresher courses related to HIV care and treatment according to needs identified 
during routine data analysis, supervision and mentorship activities.   
 Standardize mentorship and supervision by developing a mentorship and supervision tool 
and reporting format that should document task shifting best practices, challenges and 
actions engaged to address issues met.  
 Innovative initiatives previously adopted in HIV treatment and care program like 
involvement of the community and performance based financing should be reviewed and 
reinforced in order to improve the quality of care as well as clinical and medical 
adherence.  
 Optimize the use of virological monitoring to avoid premature or unnecessary switching 
to expensive 2
nd
 line ART. 
 The monitoring of early warning indicators to prevent HIV drug resistance should be 
reactivated and regularly conducted in ART programs based on task shifted care.  
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 Review the national HIV monitoring and evaluation system (TRACnet) to integrate 
missing relevant indicators related to quality of care and HIV patient care and treatment 
in compliance with national clinical guidelines.  
 Analysis of national ART program data routinely collected should be promoted in order 
to monitor and evaluate continuously the national ART program 
  Identify barriers with respect to clinical appointments associated to patients and ways to 
address them: 
o Provide additional counseling support. 
o Establish a system of ‗tracers‘ or a way to contact patients at home to prevent 
non-adherence by chronic defaulters. 
o Adapt the service delivery system to overcome systemic barriers—a client 
friendly clinic, flexible hours, ‗one-stop shop‘ (that is adjusting appointments so 
that patients could complete all required appointments with physician, counselor, 
social worker and other medical specialist as required during the same clinical 
visit). 
o Setting goals to not miss appointments in performance based financing system 
(PBF). 
o Allow patients to take an extra supply of medications with him/herself when 
travelling. 
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APPENDICES 
APPENDIX 1: DATA ABSTRACTION TOOLS (ENGLISH VERSION) 
Appendix 1.1.: Data abstraction tool for district hospital, central level and partners 
1. Identification 
1.1. Name DH/Institution/Partner: ___________________________________ 
1.2. Date of Abstraction: _______/_______/______ (dd/mm/yyyy) 
2.  Achievement of key activities of task shifting 
2.1. Training 
Number of training courses planned Number of trainings conducted 
2010 2011 2010 2011 
Number of 
trainings 
Number of 
nurses targeted 
Number of 
trainings 
Number of 
nurses targeted 
Number of 
trainings 
Number of 
nurses trained 
Number of 
trainings 
Number of 
nurses trained 
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2.2.  Mentorship/supervision 
Number of 
supervisions/mentorships 
planned 
Number of 
supervisions/mentorships 
conducted 
Main issues identified 
2010 2011 2010 2011 2010 2011 
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Appendix 1.2.: Data abstraction tool for the health centres 
1. Identification  
1.1. Name HC: ___________________________________ 
1.2. Date of Abstraction: _______/_______/______ (dd/mm/yyyy) 
2. Human Resource 
No Functions  Main responsibility for task shifting program Training information   
NB: mark ―X‖ to appropriate case 
Full trained  Still in training Not yet trained 
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3. Availability of job-aids at PHC 
Type of Job-aids Availability (Yes/No) 
Summary of national eligibility criteria for ART  
WHO staging and basic opportunistic infections (e.g., TB, thrush),   
Steps in initiating a patient on ART  
ART patient monitoring schedules  
Tool for identifying and managing basic side effects of ARV drugs  
Tool for identification of treatment failure  
Criteria for and steps in referring an ART client to physician care  
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4. Indicators for ART program 
Indicators  
Period : at the end of December 2011 
Females 
>=15 years 
Females 
<15 years 
males 
>=15 years 
males  
<15 years 
Total 
Number of persons in pre- ART       
Number of patients enrolled and medically eligible for ART but not yet on ART       
Number of patients lost to follow-up before start of ART      
Number of patients dead before start of ART      
Number of patients transferred out before start of ART      
Cumulative number of patients ever enrolled in HIV care       
Number of new patients on ART in the last month      
Number of patients currently on the first- line regime      
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Number of patients currently on the second-line regime       
Cumulative number of patients on ART      
Number of ART patients lost to follow-up      
Number of ART patients dead      
Number of ART patients who transferred out      
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Appendix 1.3.: data abstraction tool for patient 
1. Identification  
1.1. Name of Primary Health Centre  (PHC):__________________________________ 
1.2. HIMS code of PHC: __________________________________ 
1.3. Patient number: _____________________________ 
1.4. Patients ID :_________________________(HIMS code + Patients number) 
1.5. Date of Abstraction: _______/_______/______ (dd/mm/yyyy) 
NB: patient ID is composed by HIMS Code of the PHC and sequential numbers of randomly 
selected subjects. 
1.6. Date of birth: ______/_______/________ (dd/mm/yyyy) 
1.7. Sex: (male/female):__________________ 
2. Treatment information  
2.1. Date of initiation on ART: ______/_______/________ (dd/mm/yyyy) 
2.2. How many appointments have not been respected since initiation on ART? _____ 
2.3. Was the patients ever referred to specialty medical services (Yes/No):_________ if yes, 
where?_____________________________ 
3. Patients outcomes  
Indicators Baseline After 6 months of treatment on ART 
Measure Date Measure Date 
Weigh (Kg)     
CD4 (mm
3
)     
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4. Side effect, opportunistic infection and other health problems identified after initiation 
on ART 
Date of 
consultation 
Side effect identified Opportunistic infection 
identified 
Other health 
problems identified 
    
    
    
    
 
5.  Outcomes  
According to the medical 
record, has the patient 
Yes  No If yes, 
occurring 
date of event 
If yes, reason 
Been lost to follow-up     
Died     
Substituted drugs     
Switched regimen     
Stopped ART Completely                     
Transferred out      
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APPENDIX 2 : OUTIL DE COLLECTE DES DONNEES (VERSION FRANÇAISE)  
Appendix 2.1 : Outil de collecte des donnees pour l’ hopital de district, le niveau central et les partenaires  
1. Identification 
1.1. HD/Institution/Partnaire: ___________________________________ 
1.2. Data: _______/_______/______ (jj/mm/aaaa) 
2. Réalisation des activités clés liée au transfert des tâches relatives aux soins du VIH vers les infirmiers dans les services 
d’ARVs) 
2.1. Formation  
Nombre de formations planifiées  Nombre de formations réalisées  
2010 2011 2010 2011 
Nombre de 
formations 
Nombre 
d‘infirmiers 
ciblés  
Nombre de 
formations 
Nombre 
d‘infirmiers 
ciblés 
Nombre de 
formations 
Nombre 
d‘infirmiers 
formés  
Nombre de 
formations 
Nombre 
d‘infirmiers 
formés 
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2.2. Mentorship/supervision 
Nombre de 
supervisions/motorships 
planifiés 
Nombre de 
supervisions/motorships 
réalisés  
Principaux problem identifiés  
2010 2011 2010 2011 2010 2011 
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APPENDIX 2.2 : OUTIL DE COLLECTE DES DONNEES POUR LES CENTRES DE SANTE 
1. Identification 
1.1. Nom du centre de santé (CS): ___________________________________ 
1.2. Date  de collecte des données: _______/_______/______ (jj/mm/aaaa) 
2. Resource Humaine 
No Functions  Principal responsabilité par rapport au programme de 
transfert des tâches relatives aux soins du VIH vers les 
infirmiers 
Information sur les formations 
NB: mettez ―X‖ a la case appropriée 
a reçu une 
formation 
complète  
est encore 
en 
formation 
n‘est pas 
encore 
formé 
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3. disponibilité des documents ou outils de travails aux CS 
Type d’outils ou document de travail Disponible (Oui/Non) 
Sommaire des critères d‘éligibilité aux ARVs   
Stades de l‘OMS et les infections opportunistes    
Etapes d‘initiation du patient aux ARVs   
Carnet de rendez-vous pour le suivi des patients sous ARVs  
Outil d‘identification et de gestion des principaux effets secondaires dus 
au traitement aux ARVs 
 
Outils d‘identification de l‘échec du traitement aux ARVs   
Critères et étapes pour référer un patients sous ARVs chez le médecin   
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4. Indicateur pour le programme de prise en charge et traitement aux ARVs 
Indicateurs  
Période : fin Décembre 2011 
Femmes  
>=15 ans 
Females 
<15 ans 
Hommes 
>=15 ans 
Hommes  
<15 ans  
Total 
Nombre des personnes enrôlées dans le pre- ARVs      
Nombre de patients enrôlés et éligibles aux ARVs mais qui ne sont pas 
initiés aux ARVs   
     
Nombre de patients perdus de vue avant qu‘ils commencent les ARVs      
Nombre de patients mort avant qu‘ils commencent les ARVs      
Nombre de patients transférés ailleurs avant qu‘ils commencent les ARVs      
Nombre cumulatif des patients qui sont enrôlés dans le programme de 
traitement du VIH  
     
Nombre des nouveaux patients initiés aux ARVs au cours du dernier mois      
Nombre de patients actuellement traités sous le régime de première-ligne       
Nombre de patients actuellement traités sous le régime de seconde-ligne       
Nombre cumulative des patients sous ARVs      
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Nombre des patients perdus de vue      
Nombre de patients morts      
Nombre de patients transférés ailleurs       
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Appendix 2.3. Outil de collecte des donnees pour le patient 
1. Identification  
1.1. Nom du centre de santé (CS):__________________________________ 
1.2. Code SIS (Système d‘Information Sanitaire) du CS: _______________ 
1.3. Numéro du patient : _________________________ 
1.4. Le code du patient: _________________________ (code SIS+Numero du patient) 
1.5. Date de collecte des données: _______/_______/______ (jj/mm/aaaa) 
NB: Le code du patient est compose du code SIS du CS et du numéro séquentiel des sujets 
sélectionnés pour l’étude. 
1.6. Date de naissance : ______/_______/________ (jj/mm/aaaa) 
1.7. Sexe: (masculin/féminin):__________________ 
2. Information sur le traitement  
2.1. Date d‘initiation aux ARVs: ______/_______/________ (jj/mm/aaaa) 
2.2. Combien de rendez-vous ratés depuis l‘initiation aux ARVs? ___ 
2.3. Est que le patient n‘a jamais été transféré dans un autre service médical spécialisé ? 
(Oui/Non):_________ si oui, lequel ? __________________________________ 
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3. Résultats du traitement sur le patient  
Indicateur Baseline Après 6 mois de traitement aux 
ARVs  
Mesure Date Mesure Date 
Poids (Kg) 
    
CD4 (mm
3
)     
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4. Effets secondaires, infections opportunistes et autres problème de santé identifiés après initiation aux ARVs  
Date de 
consultation 
Effets secondaires  identifiés infections opportunistes 
identifiés 
autres problème de santé 
identifiés 
    
    
    
    
5. Aboutissements   
Selon le dossier médical du malade, est-ce que :  Oui Non Si oui, la date à laquelle 
cela est arrivé 
Si oui, donnez la 
raison 
le patient est perdu de vue     
le patient est  mort     
ses médicaments ont été remplacés      
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le patient a été mis sous un autre régime d‘ARVs     
le patient a arrêté complètement le traitement aux 
ARVs                  
    
le patient a été transféré ailleurs     
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APPENDIX 3: PARTICIPANT INFORMATION SHEET (ENGLISH VERSION) 
       UNIVERSITY OF THE WESTERN CAPE 
                                  School of Public Health 
      Private Bag X17 ● BELLVILLE ● 7535 ● South Africa 
           Tel: 021- 959 2809, Fax: 021- 959 2872 
 
Appendix 3.1. Confidentiality agreement  
Effectiveness of task shifting in antiretroviral treatment services in primary health care centres in 
Gasabo district, Rwanda. 
I, _____________________________________________________________ (print name), 
agree to abide by the following rules and restrictions on the use of data from the study entitled 
―Effectiveness of task shifting in antiretroviral treatment services in primary health care centres 
in Gasabo district, Rwanda.‖  
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1. I WILL NOT remove study participants records with direct identifiers (such as participants 
names or addresses), whether in paper or electronic format, from the study site without the 
explicit and written permission of the Study Coordinator.  
2. I WILL NOT divulge study participants information to other persons other than the study 
personnel. The release of this information will only be done with full consent of the study 
participants.  
3. I WILL protect all electronic study participants‘ records using password of at least 8 
characters. This protection includes the participants‘ records that constitute the study dataset.  
4. I WILL NOT delete/shred/destroy any study paper or electronic records unless with specific 
written instructions from the Study Coordinator. 
5. I WILL NOT give the access password(s) to any persons other than those who have signed 
the data use agreement.  
6. I WILL treat all data at my desk/site confidentially and maintain paper records that could 
directly or indirectly identify any individual in a designated locked file cabinet. 
7.  I WILL keep all hard copies of preliminary data locked in a file cabinet when not in use and 
will shred them when they are no longer necessary to my analysis.  
8. I WILL NOT produce a back-up data tape of the study datasets except as required for the 
maintenance of the system. I WILL ensure that that the back-up datasets are also stored 
according to the full confidentiality guidelines mentioned above. 
9. I WILL NOT remove paper or electronic files, records or databases from the worksites. 
10.  I WILL NOT remove hard copies of study participants records or confidential 
communications, containing sensitive data and information from the worksites. 
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11.  I WILL NOT remove from the work site tabulations or data in any format that could 
directly or indirectly identify any individual. I WILL NOT divulge any information on 
tabulations and other data formats to non-study personnel.  
 I have read and understood this document on the use of data from the Study.  
Signature: __________________________________ Date: _______________ 
Name: ____________________________________  
Role in the study ______________________________________________  
Study Coordinator_____________________________ 
Signature___________________________________ Date: ______________ 
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Appendix 3.2.: Participant information sheet 
Study Title: Effectiveness of task shifting in antiretroviral treatment services in primary health 
care centres in Gasabo district, Rwanda. 
Principal Investigator: Adeline Kabeja  
Research purpose: I am a final year MPH student at the SOPH, University of the Western Cape 
and I am required to do a Mini-thesis. My research project focuses on assessment of 
effectiveness of task shifting in ART services in 16 primary health centres under located in 
Gasabo district The purpose of the study is to evaluate the task shifting program, to determine 
whether it has been implemented and is going as intended and to propose improvements needed 
to readjust the task shifting program so it can reach its primary goal to increase accessibility of 
people living with HIV to ARV therapy and to improve nurse capacity in HIV patient care. 
Findings will be used to improve and readjust task shifting program for a better success of task 
shifting in Rwanda     
Information on research: We are inviting you to allow us to evaluate what is done in the 
primary health center under your responsibility. We will explain to you the purpose of the 
evaluation, the procedures to be used, and the possible benefits and risks of participation. We are 
requesting your participation in this study because nurses working here have been trained and 
authorized to prescribe ART and follow HIV patients in need. If you agree, the facility under 
your responsibility will participate in the evaluation which will be done today. The evaluation 
will take no more than a few hours to complete. During the evaluation we will check information 
related to budget used in HIV care and treatment program, nurses involved in HIV care and 
treatment, ART program data and patients outcomes.  
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Risks: There is a slight risk of loss of privacy by participating in this study but procedures have 
been put into place to minimize this risk. The research records will be confidential, as the law 
requires. If a request for any of the information makes you uncomfortable, you can skip this item 
or stop the evaluation.  
Benefits: There is no direct benefit to health facility in participating in this study. The 
information gathered, however, will help our health policy makers to improve programs and 
policies for quality health care provided by nurse in ART services delivery. 
Confidentiality: name of participants will not appear on the data abstraction tools. Patients and 
nurses will be assigned a code. Information collected during data abstraction will not be shared 
directly with your supervisors. The information gathered will be kept in a locked and secure 
place for up to five years and during that time only the study team staff will have access to this 
information. Additionally, members of the Rwandan National Ethics Committee and UWC 
Ethics Committee may look at the research records. After five years, the hard copies of the study 
files will be destroyed. All study staff will be required to sign confidentiality agreements.  
Voluntary participation: You are being invited to allow participation of the facility under your 
responsibility in this study. Your consent is completely voluntary and you have the right to stop 
the evaluation at any time. You do not have to provide information on any questions that you do 
not want to answer. Your decision allowing participation of health facility or not will in no way 
affect work climate or working conditions at this health facility.  
For additional information: If you would like to have more information about the study, you 
may contact:  
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Adeline Kabeja, 
Principal Investigator, Rwanda Biomedical centre/EID Division 
P. O Box 2717,  
Boulevard de la Révolution, 
Kigali, Rwanda  
Tel: +250 0788462552  
E -mail: adelinekabeja@yahoo.fr or adelinekabeja@gmail.com  
Prof. Helen Schneider  
School of Public Health 
University of Western Cape 
Private Bag X17, Bellville, 7535, 
Tel: +27 21 959 2809 
Fax: +27 21 959 2872 
Email: hschneider@uwc.ac.za 
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Appendix 3.3: Informed consent form  
Title of Research Project Effectiveness of task shifting in antiretroviral treatment services in 
primary health care centres in Gasabo district, Rwanda. 
The study has been described to me in language that I understand well. Thus, I freely and 
voluntarily agree to engage participation of the primary health center (s) under my responsibility. 
All my questions about the study have been answered. I understand that identity of patients and 
nurses will not be disclosed and that I may withdraw the facility under my responsibility from 
the study without giving a reason at any time and this will not affect my job in any way at this 
facility or any other facility in Rwanda.  
Signed by data collector:  
Signed by head of primary health centre: 
Date_____________________                                           Place____________________  
If you have any questions, please do not hesitate to ask anyone of the study team or contact:  
Adeline Kabeja, 
Principal Investigator, Rwanda Biomedical centre/EID Division 
P. O Box 2717,  
Boulevard de la Révolution, Kigali- Rwanda  
Tel: +250 0788462552  
E -mail: adelinekabeja@yahoo.fr or adelinekabeja@gmail.com  
Study ID Number : 2974499 
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APPENDIX 4: FICHE D’INFORMATION AUX PARTICIPANTS (VERSION FRANÇAISE) 
       UNIVERSITY OF THE WESTERN CAPE 
School of Public Health 
      Private Bag X17 ● BELLVILLE ● 7535 ● South Africa 
           Tel: 021- 959 2809, Fax: 021- 959 2872 
Appendix 4.1 : Accord de confidentialite  
Efficacité du transfert des tâches relatives aux soins du VIH vers les infirmiers au sein des 
services de traitements antirétroviraux des les centres de santé dans le district de Gasabo, au 
Rwanda. 
Moi, _____________________________________________________________ (Nom), 
j‘accepte de me conformer aux règles et restriction suivants, relatives à l‘utilisation des données 
de l‘étude intitulée: «  Efficacité du transfert des tâches relatives aux soins du VIH vers les 
infirmiers au sein des services de traitements antirétroviraux des les centres de santé dans le 
district de Gasabo, au Rwanda». 
1. JE ne collecterai les informations d'étude avec les marques directes (telles que des noms ou 
des adresses de participants), soit sur un papier ou en format électronique sans permission 
 
 
 
 
96 
 
explicite et écrite du coordonnatrice d'étude. 
2. JE ne divulguerai pas les informations des participants d'étude à d'autres personnes, outres 
que le personnel d'étude. La publication des informations sera seulement faite avec le plein 
consentement des participants d'étude. 
3. JE protégerai tous les données électroniques de participants de l'étude, en utilisant le mot de 
passe d‘au moins 8 caractères. 
4. JE ne supprimerai /déchiquèterai/détruirai n‘importe quelle information d‘étude, qu‘elle soit 
sur papier ou électronique à moins d‘avoir des instructions spécifiques écrites du 
coordonnatrice d'étude 
5. JE ne donnerai à personne le mot de passe sauf s‘il a signé l'accord d'utilisation de données. 
6. JE traiterai confidentiellement toutes les données à mon bureau et maintiendrai les 
questionnaires  qui pourraient directement ou indirectement identifier l'individu dans un 
coffret de dossier verrouillé. 
7. JE maintiendrai enfermer à clef dans un coffret de dossier, tous les imprimés des données 
préliminaires quand  ils ne seront pas en utilisation et les déchiquetterai quand ils  ne sont 
plus nécessaires à l‘analyse. 
8. JE ne faire pas une bande de sauvegarde (back up) de l‘ensemble des données d'étude, 
excepté s‘il est demandé de le faire pour maintenir le system. JE m'assurerai que les bandes 
de sauvegarde des données sont également stockés selon les directives de confidentialité 
mentionnées ci-dessus. 
9. JE n'enlèverai pas les questionnaires ou les données électroniques du milieu de travail. 
10. JE n'enlèverai pas du milieu de travail,  les imprimés des questionnaires des participants de 
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l'étude ou les communications confidentielles, contenant des données d‘information 
sensibles. 
11. JE n'enlèverai pas du milieu de travail les tabulations ou des données de n‘importe quel 
format qui pourrait directement ou indirectement identifier l'individu. JE ne divulguerai 
aucune information sur des tabulations et d'autres formats de données aux personnes non 
impliquées dans l‘étude 
J'ai lu et ai compris ce document sur l'utilisation des données de l'étude. 
Signature: ________________________________Date: ____________________ 
Nom: ____________________________________  
Role: ____________________________________  
Coordinatrice de l‘etude ______________________________________________  
Signature: ________________________________ Date: _____________________  
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Appendix 4.2 : Fiche d’information aux participants 
Sujet d’étude: Efficacité du transfert des tâches relatives aux soins du VIH vers les infirmiers au 
sein des services de traitements antirétroviraux des les centres de santé dans le 
district de Gasabo, au Rwanda. 
Principal investigateur: Adeline Kabeja 
But de la recherche: Je suis étudiante de dernière année de l‘Ecole de Santé Publique à 
l‘Université de Western Cape et je fais mon mémoire de Maitrise. Mon projet de recherche se 
base sur l‘évaluation de l‘efficacité du transfert des tâches relatives aux soins du VIH vers les 
infirmiers au sein des services de traitements antirétroviraux (ARV) des 16 centres de santé 
situés dans le district de Gasabo, au Rwanda. L‘objet de mon étude est d‘évaluer ce programme 
de transfert des tâches relatives aux soins du VIH vers les infirmiers, de déterminer s‘il a été mis 
en place et conduit comme prévu et de proposer les améliorations nécessaires à son réajustement. 
Ainsi ce programme peut atteindre son objectif principal d‘amélioration de l‘accessibilité aux 
traitements antirétroviraux et d‘augmenter les capacités des soignants (infirmiers) dans la prise 
en charge des patients du VIH. Les conclusions serviront à l‘amélioration et à la réadaptation de 
ce programme de transfert des tâches relatives aux soins du VIH vers les infirmiers en vue de sa 
réussite. 
Informations de recherche: Nous vous invitons à nous autoriser à évaluer le travail au sein du 
Centre de Santé dont vous avez la responsabilité. Nous allons vous expliquer le but de cette 
évaluation, les procédures à utiliser, les avantages et risques de participation. Nous vous 
demandons à participer à cette étude parce que les infirmiers de ce centre de sante ont été formés 
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et autorisés à prescrire les antirétroviraux et faire le suivi des patients du VIH dans le besoin. Si 
vous acceptez, votre centre de sante participera à l‘évaluation d‘aujourd‘hui. Cette évaluation ne 
va durer que pas plus que quelques heures. Pendant l‘évaluation nous allons analyser 
l‘information relative au budget dépensé dans le programme de prise en charge et traitement par 
les ARVs, les infirmiers qui y sont impliqués, les données du programme ARV ainsi que les 
résultats du traitement sur les patients. 
Risques: Par la participation à cette étude, il ya un faible risque de manquement à la vie privée 
mais des procédures ont été mises en place pour minimiser ce risque et les données de cette 
recherche seront confidentielles comme la loi l‘exige. Si une demande d‘information vous met 
mal à l‘aise, vous pouvez l‘éluder ou mette fin à cette évaluation. 
Avantages: Il n‘y a aucun avantage direct découlant de la participation de votre centre de sante  
à cette étude. Mais les informations recueillies aideront les planificateurs à améliorer les 
programmes et les politiques de santé pour une qualité des soins de santé assurés par les 
infirmiers dans les services de prise en charge ARV 
Confidentialité: les noms des participants ne vont pas figurés aux formulaires de collecte de 
données. Un code sera attribué aux patients et aux infirmiers. Les informations recueillies durant 
la collecte des données ne seront pas partagées avec vos superviseurs. Les informations 
collectées seront gardées dans un endroit sécurisé pendant cinq ans et durant cette période, seuls 
les membres du groupe de recherche y accéderont. En outre, les membres du Comité Nationale 
d‘Ethique Rwandaise et du Comité d‘Ethique de l‘UWC pourront consulter les notes de 
recherche. Après cinq ans, les copies imprimées des fichiers de cette recherche seront détruites. 
Tous les membres de l‘équipe de recherche devront signer des accords de confidentialité. 
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La participation est volontaire : Vous êtes invité à autoriser la participation de votre centre de 
sante à cette recherche. Votre consentement est totalement volontaire et vous avez le droit de 
stopper l‘évaluation à n‘importe quel moment. Vous n‘avez pas à répondre à une question pour 
laquelle vous ne voulez pas répondre. Votre décision permettant ou non la participation du centre 
de sante dans cette étude n‘affectera en rien le climat et les conditions de travail au sein de cette 
formation sanitaire.pas le climat et les conditions de travail dans cette formation sanitaire  
Informations complémentaires: Si vous voulez avoir plus d‘informations concernant cette 
étude, vous pouvez contacter : 
Adeline Kabeja, 
Investigateur Principal, Rwanda Biomedical centre/EID Division 
P. O Box 2717, Boulevard de la Révolution, 
Kigali, Rwanda  
Tel: +250 0788462552  
E -mail: adelinekabeja@yahoo.fr or adelinekabeja@gmail.com  
Prof. Helen Schneider  
School of Public Health 
University of Western Cape 
Private Bag X17,Bellville, 7535, 
Tel: +27 21 959 2809 
Fax: +27 21 959 2872 
Email: hschneider@uwc.ac.za 
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Appendix 4.4: Accord de consentement  
Titre du projet de recherche : Efficacité du transfert des tâches relatives aux soins du VIH vers 
les infirmiers au sein des services de traitements antirétroviraux des les centres de santé dans le 
district de Gasabo, au Rwanda. 
L‘étude m‘a été décrite de façon très compréhensive. Ainsi, librement et volontairement je donne 
mon accord de participation du Centre de Santé sous ma responsabilité. Toutes les questions 
relatives à cette étude m‘ont été répondues. Je comprends que l‘identité des patients et des 
infirmiers ne seront pas divulgués et que je pourrais retirer ma formation sanitaire de cette étude 
sans être obligé d‘en donner la raison et à n‘importe quel moment et que cela n‘affectera en rien 
mon emploi au sein de cette formation sanitaire et dans toute autre formation sanitaire du 
Rwanda. 
Signature de l‘enquêteur ________________________________  
Signature du titulaire du centre de sante:_______________________________ 
Date_____________________  
Si vous avez une question, n‘hésitez pas a contacte le chef de l‘équipe de recherche  
Adeline Kabeja, 
Investigateur Principale, Rwanda Biomedical centre/EID Division 
P. O Box 2717,  Boulevard de la Révolution, 
Kigali- Rwanda  
Tel: +250 0788462552  
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E -mail: adelinekabeja@yahoo.fr or adelinekabeja@gmail.com  
ID Number: 2974499 
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APPENDIX 5: ADDENDUM OF DATA ABSTRACTION TOOL FOR THE HEALTH CENTRE  
1. Health centre: ___________________________________ 
2. Fonction  
Fonction Réponse (X) 
Nurse (A0, A1, A2)  
Social worker (A1, A2)  
Psychologist    
Nurse assistant   
3.  Training :  
Full trained  Still in 
training 
Not yet 
trained 
   
4. Tasks : Put (X) to task under your responsability 
Phase du 
traitemener  
HIV clinical tasks performed by nurses  Réponse 
Yes No 
Pre-ARV Initial physical exam/staging   
Ordering CD4 count   
Assessment of ART eligibility   
Follow-up of noneligible patients   
Cotrimoxazole refill   
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Preparation for 
ART 
Explain goal, benefit and risks of ART   
Counsel patient on the importance of adherence and explore 
optionsto maintain long-term adherence 
  
Prepare the individual patient and/or patient‘s caregiver to 
initiate ART 
  
Establish readiness of the patient to start ART   
Explain food/other diet restrictions where needed   
Eligibility for ART Establish medical eligibility for ART in a naive patient   
Request laboratory test relevant to specific ARV drug 
initiation (pregnancy test if efavirenz or haemoglobin if 
zidovudine) 
  
Initiation of ART Recommend first-line ARV regimen for ART-naive patient   
Recommend first-line ARV regimen with TB coinfection   
Recommend first-line ARV regimen in a pregnant woman (no 
PMTCT) 
  
Decide on when to start ART in eligible patients who have an 
active OI (taking into account if stabilization of OI is needed 
and possible) 
  
Prescription of ART Prescribe first-line ART    
Clinical Monitoring Take weight   
Take vital signs   
Determine functional status   
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Monitor and support adherence   
Request CD4 test   
Respond to New 
Signs and Symptoms 
and Possible 
Side-Effects 
Recognize/manage self-limiting ARV drug side-effects and 
encourage/assist consultation or clinic visit when necessary 
  
Manage headache and fever 2 weeks after initiation of 
d4T/3TC/NVP (malaria test negative) 
  
Manage a patient on d4T/3TC/NVP since 3 weeks who 
develops a generalized dry skin rash without other symptoms 
  
Manage a patient on AZT/3TC/NVP since 2 weeks with 
nausea without other symptoms 
  
Manage herpes zoster 4 weeks after ART initiation   
Manage oral thrush 8 weeks after ART initiation (patient at 
WHO clinical stage 4 at initiation) 
  
Recognize treatment failure from clinical symptoms   
Manage TB 
Coinfection 
Initiate INH prophylaxis   
Dispensing and 
Arranging Follow-
Up 
Dispense ARV and other drugs   
Arrange follow-up visit   
Clinical Monitoring Monitor and support ART adherence   
Take weight   
Take vital sings   
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Determine functional status   
Request CD4 test   
Recognize/manage self-limiting ARV side-effects   
Manage headache and fever 10 months after initiation of 
d4T/3TC/NVP 
  
Treat a patient on d4T/3TC/NVP with tingling in fingers and 
toes since 2 weeks 
  
Manage oral thrush 24 months after ART initiation (WHO 
clinical stage 4 at initiation) 
  
Identify symptoms such as chronic cough and/or chronic fever 
and/ or weight loss as a TB suspect 
  
Request sputum exam (Ziehl-Neelsen) for TB suspects   
Request additional exams (such as X-ray) to establish the 
diagnosis of TB in TB suspects with negative sputum results  
  
Initiate TB/ART co-treatment with a first episode of 
pulmonary TB with positive sputum results 
  
After decision for initiation of TB treatment, provide TB 
treatment to sputum-positive pulmonary TB patients with HIV 
  
After decision for initiation of TB treatment, provide TB 
treatment to patients other than sputum-positive pulmonary TB 
patients 
  
Monitor TB treatment response   
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Recognize side-effects of TB and/or HIV medications and 
encourage/ assist consultation or clinic visit when necessary 
  
Provide combined TB/ART DOT if necessary in a patient who 
is on ART > 3 months 
  
Dispensing and 
Arranging Follow-
Up Visits 
Dispense ARV and other drugs   
Arrange follow-up visits   
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Addendum of data abstraction tool for the health centres 
Titre de l’etude: Efficacité du transfert des tâches relatives aux soins du VIH vers les infirmiers 
au sein des services de traitements antirétroviraux des les centres de santé dans le district de 
Gasabo, au Rwanda. 
5. Nom du Centre de Sante: ___________________________________ 
6. Mettez une digne de croix (X) devant la fonction qui vous correspond 
Fonction Réponse (X) 
Infirmière (A0, A1, A2)  
Social (A1, A2)  
Psychologue   
Auxiliaire  
7. Formation  
a reçu une 
formation 
complète  
est encore 
en 
formation 
n‘est pas 
encore 
formé 
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8. mettez une Signe de croix (X) devant les taches que vous faites 
Phase du 
traitemener  
Taches faites dans le cadre du « Task Shifting » dans le 
service ARV 
Réponse 
 
PRE-ARV Oui Non 
 Examen initiale et classification du stade de l‘OMS   
Demande d‘examen de CD4   
Sélection des patients éligibles aux ARVs   
Suivie des patients pas encore eligibles aux ARV   
Approvisionner les contrimoxazole   
ART CARE Oui Non 
Preparation for 
ART 
Expliquer l‘importance de la prise des ARVs aux patients   
Expliquer aux patients l‘importance d‘une bonne adhérence   
Déterminer si le patient est prêt pour commencer les ART   
Expliquer le régime alimentaire et les restrictions nécessaires 
aux patients sous ARVs 
  
Eligibility for 
ART 
Déterminer l‘éligibilité médicale chez le patient qui n‘a jamais 
pris les ARV 
  
Demander les examens de labo nécessaire pour spécifier les 
types de médicaments à prescrire 
  
Initiation of 
ART 
Recommander la première ligne des ARVs   aux patients qui 
n‘ont jamais pris les ARV et aux patients avec une coïnfection 
de la tuberculose et  
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Pour les patients éligibles qui on une infection opportuniste 
active, décider quand commencer les ARVs en tenant en 
compte de la possibilité et de la necessite de stabiliser les IO 
  
Prescription of 
ART 
Prescrire la première ligne des ARVs   
EARLY FOLLOW-UP (UP TO 3 MONTHS FROM STARTING ART) 
Oui Non 
Clinical 
Monitoring 
Prise de poids   
Prise des signes vitaux   
Monitorage et soutient de l‘adhérence    
Demande du test de CD4   
Respond to New 
Signs and 
Symptoms and 
Possible 
Side-Effects 
Reconnaissance et prise en charge du début des effets 
secondaires aux ARVs et encourager/assister une consultation 
clinique si nécessaire 
  
Gérer des céphalées et fièvre qui surviennent après 2 semaines 
d‘initiation au D4T/3TC/NVP si le test de malaria est négatif 
  
Gérer des patients mis sous  D4T/3TC/NVP qui développe une 
éruption cutanée généralisée sans autre signe 
  
Gérer des patients mis sous   depuis 2 semaines 
AZT/3TC/NVP qui ont des nausées  sans autres signe 
  
Gérer de l‘herpes zoonotique après 4 semaines d‘initiation aux 
ARV 
  
 
 
 
 
111 
 
Gérer de la candidose buccale 8 semaines après initiation aux 
ARVs chez les patients qui étaient au stade 4 de l‘OMS au 
moment de l‘initiation aux ARVs 
  
Reconnaitre l‘échec du traitement à partir des symptômes 
cliniques  
  
Manage TB 
Coinfection 
 
 
Identifier comme cas suspect de la tuberculose les patients 
VIH+ qui ont les symptômes comme toux chronique ou fièvre 
ou perte de poids et les aider/orienter a faire une consultation 
clinique 
  
Demander l‘examen de crachat (Ziehl-Neelsen) aux cas 
suspect de la TB 
  
Décider n‘initier le traitement de TB et donner le traitement de 
la TB 
  
Suivre la réponse au traitement de la TB   
Initier al prophylaxie a l‘isoniazid    
Initier la prophylaxie a l‘INH   
Traiter les démangeaisons dues à l‘éruption cutanée (rash) 
chez les patients sous la prophylaxie au co-trimoxazole 
  
Dispensing and 
Arranging 
Follow-Up 
Donner les ARVs et autres médicaments   
Donner les RV pour les visites de suivie    
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LONG-TERM FOLLOW-UP (3 MONTHS AFTER INITIATION OF ART) 
Oui Non 
Clinical 
Monitoring 
Monitorage et soutient de l‘adhérence   
Prise de poids   
Prise des signes vitaux   
Demande du test de CD4   
Reconnaissance et prise en charge du début des effets 
secondaires aux ARVs  
  
Prise en charge des céphalées et fièvre 10 mois après initiation 
au D4T/3TC/NVP  
  
Traiter les patients mis sous  D4T/3TC/NVP qui ont des 
picotements dans les doigts et les orteils depuis 2 semaines 
  
Gerer la candidose buccale 24 mois après initiation aux ARVs 
(classification au stade 4 OMS a l‘initiation aux ARV) 
  
Identifier comme cas suspect de la tuberculose les patients 
VIH+ qui ont les symptômes comme toux chronique ou fièvre 
ou perte de poids  
  
Demander l‘examen de crachat (Ziehl-Neelsen) aux cas 
suspect de la TB 
  
Initier le co-traitement TB/ARVs a l‘identification du premier 
épisode de TB pulmonaire 
  
Assure le suivi de la reponse au traitement de TB   
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Reconnaitre les effets secondaires dus aux medicaments contre 
la Tuberculose et le VIH et assister le patient pour avoir une 
consultation clinique si besoin 
  
Dispensing and 
Arranging 
Follow-Up Visits 
Distribution des medicaments 
 
  
Donner les RV pour le suivie du patient 
 
  
 
 
 
 
